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Quartz Crystal Microbalance with Dissipation Monitoring:  
Sensing Beyond Cell-Substrate Adhesion  
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Prof. Jun Xi 
 
The quartz crystal microbalance with dissipation monitoring (QCM-D) is an 
ultrasensitive mechanical sensing device that is capable of providing real-time, non-
invasive measurements of changes in resonance frequency and energy dissipation 
responses of cells immobilized onto the sensor surface. The majority of its applications in 
cell research have been limited to the study of the adhesive interaction between cells and 
the substrate surface and the evaluation of the effect of an external stimulant on the 
adhered cells. The overall objective of this thesis work was to further exploit the 
capabilities of the QCM-D in cell research by addressing important problems that are 
relevant to fundamental biology and medicine.  
In the project presented in Chapter 4, we examined the EGF-induced cell de-
adhesion, a critical step in normal embryonic development, wound repair, inflammatory 
response, and tumor cell metastasis. We were able to successfully establish the change in 
the energy dissipation factor (ΔD-response) as a specific and quantitative measure of cell 
adhesion. With this novel measure of cell adhesion, we characterized this complex de-
adhesion process, which appeared to exhibit an initial rapid cell de-adhesion, a transition, 
and a slow re-adhesion. We also shed light on the dynamic coordination of the three 
downstream pathways of epidermal growth factor receptor (EGFR) signaling in 
mediation of the epidermal growth factor (EGF)-induced de-adhesion process. In chapter 
5, continuing with the theme of applying this novel measure to the characterization of cell 
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adhesion, we examined the adhesion process of human epidermal keratinocytes on the 
implant type of surface. We identified three distinct stages of this adhesion process and 
developed several new strategies for strengthening the adhesion between soft 
tissue/skin/bone and implants. In chapter 6, we extended this novel measure of cell 
adhesion to the investigation of GPCR signaling by capitalizing the regulatory role of G 
protein-coupled receptor (GPCR) signaling in mediation of cell adhesion. We were able 
to dissect the multiplicity of the ligand-induced GPCR signaling and obtain mechanistic 
insights into the promiscuous coupling of Gαq, Gαs, and Gαi pathways as well as their 
dynamic coordination.  
In chapters 7 and 8, we explored the potential of cell-based QCM-D assay in 
detection of biomarkers. In chapter 7, we were able to relate the ΔD-response with the 
cellular response mediated by the high-affinity EGFR, the subclass of EGFR that is more 
relevant to cancer development. Lastly in chapter 8, we demonstrated that this cell-based 
QCM-D assay has the sensitivity and specificity to detect some of the potential 
biomarkers of ovarian cancer.  
In conclusion, this thesis work has demonstrated that the QCM-D is a highly 
sensitive, label-free technique that has the capabilities to probe some of the most 
important cellular processes, such as cell adhesion and cell signaling and to serve as a 
sensing platform for biomarker detection.  
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Chapter 1: Introduction to Cell Adhesion 
 
1.1 Cell Adhesion  
 Cell adhesion is defined as the ability for a cell to attach to another cell as cell-cell 
adhesion or to the extracellular matrix (ECM) as cell-substrate (or cell-ECM, cell-matrix) 
adhesion. Change in cell adhesion is a signature event in a wide range of disorders 
including, cancers
1, 2
, arthritis
3, 4
, atherosclerosis
5, 6
, and osteoporosis
7, 8
. For example, the 
progression of many cancers involves migration of the cells in a tumor from their primary 
location to different locations upon losing their adhesiveness at the primary location
1, 2
. 
At the new locations, these migrated tumors cells re-adhere, divide, and multiply 
allowing the cancer to continue to develop. A comprehensive understanding of the cell 
adhesion process can potentially provide further insight into the development of cancers 
and other cell adhesion related disorders. 
 
 
 
Figure 1.1. The four main classes of cell adhesion molecules (CAMs). (Adapted from reference 9) 
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 Both cell-cell and cell-substrate adhesion are mediated by cell adhesion molecules 
(CAMs) that reside along the plasma membrane of cells. CAMs can bind extracellularly 
to the outer membrane of neighboring cells and/or the surface of the substrate
10
, while 
connected intracellularly to the cytoskeleton
9
. There are four main classes of CAMs: 
cadherins, selectins, integrins, and the immunoglobulin (Ig) superfamily 
9, 11
 (Figure 1.1). 
Integrins are the main mediator of cell-substrate adhesion where all other CAMs are 
responsible for cell-cell adhesion.  
 
1.1.1 Cell-Cell Adhesion  
 Cell-cell adhesion is known to play an essential role in cell morphogenesis, cell 
growth, and cell communication
12
. The primary class of CAMs that mediate cell-cell 
adhesion is cadherins, which are transmembrane proteins that contain a common 
extracellular domain of about 100 amino acids known as the cadherin-specific module
13
. 
Cadherins are the key constituents of the cell-cell junction complexes – adheren junction 
and desmosomes
14
. Cadherins are also connected  to bundles of actin filaments and 
keratin filaments, respectively, by means of catenin adapter proteins
14
.  
 Another class of CAMs that mediate cell-cell adhesion is the Ig CAM 
superfamily. Members of this class contain one or more copies of the Ig fold, a structure 
with two anti-parallel beta sheets, a single transmembrane helical segment, and a 
cytoplasmic tail
15
. The Ig CAM superfamily functions in many biological processes that 
occur in a wide range of cell types. The most important function of the Ig CAM 
superfamily is its involvement in the establishment and maintenance of neural 
connections in the nervous system
16
.     
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 Selectins are another class of CAMs that mediate cell-cell adhesion. They are a 
small group of lectin-like adhesion receptors
17
. Selectin structure consists of a lectin-like 
domain, an epidermal growth factor domain, two to nine complement regulatory protein 
(CRP) repeats, a single transmembrane helical segment and a cytoplasmic tail
17
. The 
major physiological role of selectin is to bind leukocyte and facilitate its adherence to the 
surface of endothelial cells and platelets during inflammatory processes
18
.  
 
1.1.2 Cell-Substrate Adhesion   
 
 
 
 
Figure 1.2. 3D structure of focal adhesions (FAs). (Adapted from reference 19) 
 
 
 Cell-substrate adhesion plays an important role in organizing cells into tissue. In 
response to environmental cues, cell-substrate adhesion also regulates cellular behaviors, 
such as cell migration, proliferation, gene expression, and activation of signal 
transduction pathways that mediate cell growth
11
. The primary class of CAMs that 
mediate cell-matrix adhesion is integrin, which consists of heterodimers of subunits α and 
β that are non-covalently associated. Non-covalent associations, include hydrogen 
bonding, van der Waals forces, and electrostatic interactions. Both subunits of the 
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integrin are single type-I transmembrane proteins with an extracellular domain that can 
bind to extracellular matrix proteins and a cytoplasmic tail that can link intracellularly to 
the cytoskeleton
20
. This linkage allows for bi-directional force transmission across the 
plasma membrane and therefore relays information between the inside and outside of the 
cell. In mammals, there are at least 24 known integrin heterodimers, composed of 18 
different types of α subunits and 8 different types of β subunits20. The extracellular 
domain is composed of parts of both α and β subunits. The combination of the binding 
domain of the two subunits provides a diverse population of integrins with each integrin 
recognizing a distinct ECM ligand
21
. The binding of the integrin to the matrix makes 
possible the transmission of chemical signals into the cell. The chemical signal provides 
information on the location, environment, and adhesive state of the cell and dictates the 
corresponding cellular response, such as migration, differentiation, and motility
22, 23
.   
 Focal adhesions (FAs) and hemidesmosomes are the two common forms of 
integrin-dependent cell-matrix junctions
24
. Focal adhesion complexes are formed by 
clustering of integrins on the cell surface. Clusters of integrins become the central 
locations for recruiting adaptor proteins, scaffold proteins, and signaling proteins to the 
inner surface of the plasma membrane
25
 (Figure 1.2). A mature focal adhesion that varies 
in size between 1 to 5 µm contains various actin-binding proteins, kinases and 
membrane-binding proteins, such as vinculin, talin, paxillin, tensin, p130Cas, and α-
actinin. The actin-binding proteins facilitate the linkage between the actin cytoskeleton 
and the ECM
25
. The linkage allows for the generation of tension needed to modify cell 
morphology and control the traction force for cell migration. There are also multiple 
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signaling proteins (e.g., focal adhesion kinase) that transmit cell signals to regulate cell 
proliferation, survival, and migration
22
.   
 Unlike focal adhesions, hemidesmosomes (HD) connect the extracellular matrix 
to the intermediate filaments (IF) of the cytoskeleton. One important function of 
hemidesmosomes is to aid the adhesion of epithelial cells to the underlying membrane in 
stratified epithelia of skin, and in parts of the gastrointestinal and respiratory tracts
26, 27
. 
Hemidesmosome complexes contain α6β4 integrin, HD1/plectin, and the bullous 
pemphigoid (BP) antigens BP180 and BP230
26
. Alteration of the expression of 
hemidesmosomal constituents may result in several types of blistering disorders of the 
skin and are found to be involved in the development and progression of certain 
cancers
28, 29
.  
 
1.1.3 Cell Adhesion Process 
 
 
 
Figure 1.3. The cell adhesion process. First, a cell comes in contact with the substrate and loosely attaches 
onto the substrate surface. Second, the cell begins to flatten, spread its membrane and simultaneously form 
focal contact over the substrate surface. Lastly, the cell form focal adhesion complexes (FAs) that connect 
the extracellular matrix (ECM) with intracellular actin filaments, which securely anchor the cell to the 
substrate surface. With exogenous stimulation and modulation the cell can de-adhere from the ECM
30
.  
 
 
 
In general, the cell adhesion process begins with an initial stage, where a cell 
settles onto a substrate to form a very loose physical attachment to the surface. In the 
following stage, the cell flattens and begins to spread its membrane over the substrate 
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surface (Figure 1.3). During and after the cell spreading step, the transmembrane 
receptors (integrins) along with other intracellular proteins (e.g., actin, vinculin, etc.) 
form adhesion complexes with the ECM that adheres to the surface of the substrate 
31
. As 
mentioned before, the clustering of these adhesion complexes leads to the establishment 
of focal adhesions, which anchor the cell securely to the surface of the substrate. 
Conversely, disassembly of focal adhesions will reduce the level of cell adhesion and 
lead to de-adhesion of the cell
32-34
. 
 
1.2 Mediating Cell Adhesion by Cell Signaling   
 Cell adhesion molecules have been long researched as molecules involved in the 
generation of tissue structures. However, cell adhesion complexes not only play an 
important role in providing the architectural structure for tissues, but are also critically 
involved in multiple signal transduction processes
35
. The cell adhesion complex serves as 
a bi-directional path that transmits regulatory signals in and out of cells. Cells rely on cell 
signaling to coordinate various downstream effectors, various small chemical species 
(e.g., ions, enzymes) that bind to specific proteins, to regulate essential cellular functions, 
including adhesion, migration, proliferation, and differentiation
36
. The two signaling 
pathways involved in the regulation of cell-substrate adhesion that will be focused on in 
this thesis are the epidermal growth factor receptor (EGFR) pathway and the G protein 
coupled receptor (GPCR) pathways.   
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1.2.1 Epidermal Growth Factor Receptor (EGFR)  
 
 
 
 
Figure 1.4. Epidermal growth factor receptor (EGFR) signaling pathway (Adapted from reference 37) 
 
 
 The epidermal growth factor receptor (EGFR) belongs to the type 1 growth factor 
receptor tyrosine kinase (RTK) family, also known as erbB or human epidermal growth 
factor receptor (HER) family
38
. ErbB receptors are made up of an extracellular ligand-
binding region, a single transmembrane-spanning region, and a cytoplasmic tyrosine 
kinase domain. Ligands that bind specifically to EGFR are epidermal growth factor 
(EGF), transforming growth factor-α (TGF-α), herpin-binding EGF, and amphiregulin39. 
Although EGFR has affinity for diverse ligands, EGF is considered to be one of the most 
important ligands for EGFR
40
. When EGFR is activated, it is involved in signal 
transduction for the regulation of many normal physiological functions, such as cell 
growth, cell proliferation, cell motility, and cell differentiation
39
.  Abnormal expression 
and signaling of EGFR have been associated with the development of epithelial 
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malignancies in humans
41
. EGFR was the first receptor identified as a proto-oncogene
42
. 
Many studies have shown that the up-regulation of EGFR is correlated with tumor 
progression in numerous human cancers
43
.    
 Upon the ligand engagement, EGFR undergoes a conformational change, which 
leads to first receptor homo- and/or heterodimerization at the cell surface and then 
autophosphorylation of multiple tyrosine residues in the cytoplasmic domains
39
. The 
autophosphorylation activates EGFRs and initiates many downstream signaling cascades, 
including the mitogen-activated protein kinase/ extracellular signal-regulated kinase 
(MAPK/ERK) pathway, the phosphatidylinositol 3-kinase (PI3K), and the phospholipase 
C-γ (PLCγ) signaling pathway, and the signal transducer and activator of transcription 
(STAT) pathway
11
 (Figure 1.4). The ERK/MAPK, PI3K, and PLCγ pathways have been 
well studied because of their importance in regulation of cell motility, cell migration, and 
cell invasion
44, 45
.  
 The ERK/MAPK pathway is one of the principal signaling cascades that cells use 
for responding to extracellular and intracellular cues. The MAPK pathway is responsible 
for the growth factor-induced cell motility and invasion, and the ERK pathway mediates 
in cell motility and cell proliferation. Abnormal activation of ERK/MAPK pathway is a 
common occurrence in many human cancers
46
. Upon activation, the ERK1/2 signaling 
activates one of its downstream effectors calpain. As an intracellular protease, calpain is 
responsible for de-adhesion of the trailing portion of the cell during cell migration
47-49
, 
evidenced by the fact that inhibition of calpain significantly decreases the invasiveness of 
prostate tumor cells
50
. ERK1/2 signaling can also stimulate myosin light chain (MLC) 
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kinase, which subsequently phosphorylates the myosin light chain protein, allowing it to 
interact with actin filament to generate contraction forces
51
.      
 The PI3K signaling pathway is responsible for the regulation of cellular survival, 
proliferation, and growth. Activated by either receptor tyrosine kinases (RTKs) or G 
protein coupled receptors (GPCRs), the PI3K pathway induces the production of 
phospholipids to further activate a serine/threonine kinase Akt and other downstream 
effectors proteins to promote cell survival and proliferation
11
. The tumor suppressor 
PTEN is the most important regulator of the PI3K signaling pathway. Loss of PTEN had 
been linked to the uncontrolled signaling of the PI3K pathway and the development of 
cancer
49
.  Another downstream effector of the PI3K pathway is GTPase RhoA, which is 
responsible for mediating cell de-adhesion
52
.  
 The PLCγ pathway when activated by EGF is a major regulator of cell motility. 
Activation of PLCγ leads to the hydrolysis of membrane associated phospholipids, which 
then leads to the activation of protein kinase C and mobilization of actin binding proteins 
like gelsolin and cofilin that assist in cytoskeletal reorganization for cell migration
11
. 
Inhibition and gene altering studies of the PLCγ signaling pathway have shown decreased 
cell migration and invasion of fibroblasts, keratinocytes, and carcinoma cells
53, 54
.  
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1.2.2 G protein Coupled Receptor (GPCR)  
 
 
 
 
Figure 1.5. G protein coupled receptor (GPCR) signaling pathway (Adapted from reference 55) 
 
 
G protein coupled receptor (GPCR) is one of the largest families of mammalian 
proteins
56
. It is involved primarily in mediating and controlling the signal transduction 
that regulates normal physiological functions, such as secretion, neurotransmission, 
growth, cellular differentiation, and immune response
57
. It also participates in 
pathological progression of a wide variety of diseases
58
. GPCRs are known as seven 
transmembrane domain receptors (7TM) due to their common central domain consisting 
of seven transmembrane helices connected by the intracellular loops and three 
extracellular loops
59
. GPCRs can sense a wide variety of extracellular stimuli, such as 
ions, biogenic amines, purines, lipids, peptides, and proteins
57
.   
 The GPCR signaling system contains three major parts: the receptor, the 
heterotrimeric αβγ G protein, and the effector56. Binding of a ligand to the receptor 
activates the exchange of the guanidine diphosphate (GDP) in the Gα subunit of the 
heterotrimeric G protein to a guanidine triphosphate (GTP), which subsequently induces 
11 
 
 
 
the dissociation of the heterotrimeric G protein into Gα subunit and Gβγ  dimer
60
. The 
dissociated Gα subunit, depending on its major subtype (Gs, Gi/o, Gq/11, and G12/13), then 
couples with a specific effector protein to influence a diverse set of downstream signaling 
cascades that regulate biological behaviors, including apoptosis, transcription, cell 
migration, cell adhesion, and cell proliferation
61-63
 (Figure 1.5).  
 The effector of the subtype Gq mediated pathway (or Gαq/11 pathway, or Gαq 
pathway) is phospholipase C-β (PLCβ), which cleaves phospholipid phosphatidylinositol 
4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (IP3) 
64
. IP3 then binds and opens the IP3 calcium channel, which then releases calcium ions 
into the cytoplasm
64
. The Gs and Gi mediated pathways (or Gαs pathway and Gαi pathway, 
respectively) share the same type of effector, adenylyl cyclase, which is usually 
stimulated by Gαs but inhibited by Gαi
65
. Adenylyl cyclase catalyzes adenosine 
triphosphate (ATP) to 3’,5’-cyclic adenosine monophosphate (cAMP). cAMP, as a 
second messenger then activates a secondary effector protein kinase A (PKA) and other 
downstream effectors
61
. PKA, the well-studied effector, phosphorylates numerous 
metabolic enzymes, including glycogen synthase, phosphorylase kinase, acetyl CoA 
carboxylase, and others. The activation of these enzymes promotes glycogen synthesis 
and breakdown, and inhibits lipid synthesis
66
. The Gα12/13 subtype is responsible for the 
activation of  RhoGEF, which then activates the small G protein RhoA
66
, which regulates 
multiple downstream effectors. Many of these effector proteins are cytoskeletal proteins. 
A lot of research has been done on RhoA-mediated activation of Rho kinases 
(ROCK1/2), which is responsible for regulation of the formation of actin stress fibers
67
.  
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There has been research that shows overexpression or mutation of some GPCR 
subtypes in numerous cell types contributes to dysregulated growth and tumor 
development
68
. In the Gs subtype, the gsp oncogene is a mutation identified in Gαs of 
pituitary and thyroid tumors and is capable of activating adenylyl cyclase (AC) to 
promote cell growth
69
. In the Gi subtype, the gip2 oncogene has been identified and it 
promotes tumor growth through the activation of the MAPK pathways
70
. 
There has been an increasing interest in determining the mechanism of GPCR 
mediated cell adhesion, cell migration, and cell proliferation because it may give further 
insight into tumor invasion
71-74
. Gs-coupled receptors have been shown to play a role in 
promoting the activation of PKA and in controlling MAPK pathways that regulate 
remodeling of actin cytoskeleton and cell migration
75
. Studies have shown Gi-coupled 
receptors can activate Rho and Rac to regulate actin remodeling
76
. Gq-coupled receptors 
have been reported to enhance cell motility by activating PLC/PKC/calmodulin signaling 
and stimulating GTPase Rho
77
. G12/13-coupled receptors are known regulators of Rho and 
Cdc42 activation which control formation of stress fibers and filopodia, which is the 
membrane protrusion in migrating cells.  
 
1.3 Current Methods of Studying Cell Adhesion   
For decades, the study of cell adhesion has been a great interest of many 
interdisciplinary fields, including materials science, pharmacology, biophysics, etc.
78
 
Such a great interest has led to the development of various methods for studying and 
characterizing cell adhesion.  
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1.3.1 Mechanical Methods of Studying Cell Adhesion   
 
 
 
Figure 1.6. Schematic of whole cell detachment techniques. (A) Cytodetachment technique. (Adapted from 
reference 79) (B) Micropipette aspiration.  (Adapted from reference 80)  
 
 
Mechanical methods that study cell detachment events involve application of an 
external force to the adhered cells in order to free the cell from the substrate surface. The 
amount of applied force that detaches the cells is defined as the cell adhesion strength. 
Cell detachment studies can be separated into two main categories: whole cell 
detachment and cell population detachment. Whole cell detachment techniques focus on 
the removal of the entire single cell from its substrate, and the measured force represents 
the adhesion strength of a single cell. Several commonly used techniques for whole cell 
detachment are the cytodetachment and micropipette aspiration
81
. Cytodetachment 
technique uses an atomic force microscopy (AFM) probe to physically pull individual 
cells that are immobilized on a functionalized substrate away from the surface of the 
substrate
82
. The elastic deflection of the AFM probe is measured to quantify the force 
needed to detach the individual cell from the substrate surface (Figure 1.6A). The force 
per cell area gives the average shear stress of each cell
82
. The micropipette aspiration 
technique uses a micropipette to apply a suction force to aspirate the adhered cell from 
the matrix (Figure 1.6B). The minimal suction force needed to detach a cell from the 
surface provides information on the mechanical properties of the cell, such as the 
14 
 
 
 
adhesion strength of cells on different substrates materials, viscoelasticity of living cells, 
and cortical tension of cells
83
. 
 
 
 
Figure 1.7. Set-up of a biomembrane force probe (BFP). (Adapted from reference 84) 
 
 
 Cell bond detachment techniques focus on the amount of force needed to break 
the adhesive bond between the cell and the substrate. The technique used to study cell 
bond detachment is single cell force spectroscopy (SCFS), which uses a 
nano/micromanipulator or micropipette to apply force to detach the cell. A microscope is 
used to observe the cell while it’s being manipulated. SCFS offers two modes: an 
imaging mode and a force mode. The imaging mode is utilized to study the structures and 
mechanics of isolated biomolecules, cytoskeletal structures, and components of the cell 
nucleus. The force mode is used to examine the mechanical properties of the cell, such as 
the adhesion strength
85
. The most commonly used SCFS techniques for single cell 
detachment are AFM probe, biomembrane force probe (BFP), and optical tweezers. For 
the AFM probe technique, cells that are immobilized on an AFM cantilever exert their 
adhesion force onto the cantilever. The deflection of the cantilever is translated into the 
stiffness and adhesion strength of individual cells
86
. BFP is a versatile tool that has the 
ability to quantify single molecular bonds in a wide range of forces (0.1 pN to 1 nN). The 
probe used in BFP is a biotinylated erythrocyte with a streptavidin-coated glass bead 
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attached (Figure 1.7). The probe is then brought in close contact with the targeted cell, 
and adhesion will form between the probe and the cell. Once the adhesion is formed, the 
detachment force can be measured while the cell is being pulled away from the probe by 
a piezoelectric actuator
87
. Another SCFS method is optical tweezers, which uses a highly 
focused laser beam as the probe to capture and manipulate microscopic small dielectric 
particles.  The dielectric particles can be precoated with different proteins. The coated 
dielectric particle is then brought into adhesive contact with a cell attached to a surface 
(Figure 1.8). Then the particle is pulled away from the cell by increasing the laser power 
until the trapping force is strong enough to detach the particle from the cell. The 
technique is able to measure forces less than pN
88
. 
 
 
 
Figure 1.8. Schematic diagram showing an example of an optical tweezers setup. (Adapted from reference 
89)  
 
 
 Cell population detachment techniques focus on the measurement of the force 
needed to remove 50 % of the cell population. Some cell population techniques use 
centrifugation, spinning disk, and flow chamber. Centrifugation assay is a commonly 
used method to measure cell adhesion strength because of the simplicity of the 
16 
 
 
 
measurement and accessibility of the equipment in laboratories. The assay begins with 
the immobilization of cells in a multi-well plate. Then the plate is spun in a certain 
centrifugal force to detach the cells
90
. Spinning disk uses a rotating disk device to 
produce a shear stress. To apply cells on the rotating disk, cells are seeded onto a round 
glass cover slip and the cover slip is mounted onto the rotating device. Then the disk will 
rotate between 500 – 3000 rpm. The cells are counted to determine the fraction of cell 
still adhered before and after spinning
91
. Flow chamber utilizes a fluid flow to induce a 
shear stress on the cells for the measurement of adhesion strength. There are two types of 
flow chambers, the radial flow chamber and parallel chamber, and these types differ by 
the directionality of the flow of fluid within the chamber. The cells are immobilized on a 
substrate within the flow chamber and fluid is pumped in and out through the inlet and 
outlet of the chamber, respectively. The constant flow of fluid produces a shear stress to 
detach the cells from the surface. The shear stress can be controlled by flow rate of the 
fluid
92
.    
 
 
 
Figure 1.9. Schematic of techniques studying cell adhesion patterns. (A) Polyacrylamide gel-based traction 
force microscopy (PA-TFM). (Adapted from reference 93) (B) Cell micropatterning.  (Adapted from 
reference 94)  
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The study of cell attachment focuses on examination of the formation of adhesion 
bonds between the cell’s surface receptors and/or the substrate surface as well as 
examination of cellular behavior, such as changes of morphology during the cell 
attachment
78
. Examination of individual cells by assessing the interaction forces between 
a single cell and its substrate is particularly effective to provide information on the cell’s 
migration patterns and traction forces. Methods, such as polyacrylamide (PA) gel-based 
traction force microscopy (PA-TFM) and micropatterning technique, are commonly used 
for such study. PA-TFM probes the force exerted by individual cells through contact to 
the substrate surface also known as traction force. When cells attach onto the surface of a 
polyacrylamide gel embedded with fluorescent beads, the cells will produce traction force 
that will move the fluorescent beads. The displacement of the fluorescent beads can be 
tracked and used to quantify the cell adhesion and movement (Figure 1.9A)
95
. Cell 
micropatterning involves fabricating a cell substrate with microscopic features that 
imposes their effects on the cell’s attachment, shape and spreading (Figure 1.9B). This 
method has been found effective in investigating the response and sensitivity of a cell to 
specific environmental cues
96
.   
The adhesion behavior of a group of cells is often examined by either wash assay 
or microfluidic techniques. Both of these techniques can provide information on cell 
adhesion based on the balance between adhesive forces of the cells and the dispersive 
hydrodynamic forces due to the fluid flow
97
. For the wash assay, cells are cultured in 
multi-well plates under static flow conditions. After the removal of all the non-adhered 
cells with washing, the adhered cells can be analyzed with the use of cell counting, DNA 
content analysis, antibody binding, specific protein quantification, etc.
78
 In microfluidic 
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techniques, the cells cultured inside a channel are examined under dynamic flow 
conditions. Such conditions could be used to mimic the blood flow in the human body 
and allow for the examination of cell spreading and migration under the influence of a 
fluid flow.     
 
1.3.2 Imaging Methods to Study Cell Adhesion  
 
 
 
Figure 1.10. Schematic of microscopy techniques. (a) Wide field microscopy also known as epi-
fluorescence microscopy. (b) Confocal microscopy. (c) TIRF (total internal reflection fluorescence) 
microscopy. (Adapted from reference 98)  
 
 
Imaging methods focus on the visualization and tracking of the cell and its 
adhesion-associated structures, such as actin filaments and specific proteins in the focal 
adhesion complexes. Advancements in instrumentation have allowed imaging methods to 
study molecular interactions and dynamics within living cells with high resolution. Most 
of imaging methods use fluorescent tags (protein or dye) to visualize, track, and quantify 
adhesion-associated structures. The main stream imaging methods include wide field 
microscopy, point-scanning confocal microscopy, and total internal reflection 
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fluorescence microscopy. The most widely used method to image fluorescently labeled 
protein is wide field microscopy. In wide field microscopy, light passes through a filter 
set and then through a dichromatic mirror. Next, the shorter wavelength of light is 
reflected onto the sample through an objective. Finally, the longer wavelength emitted 
light from the florescent tags in the sample travels back through the objective and passes 
through the dichromatic mirror to be collected by a camera (Figure 1.10a). This technique 
provides a direct visualization of the entire cell and allows the location of the target 
molecules to be readily defined
99
. A more advanced microscopy technique is point-
scanning confocal microscopy. In this technique samples are illuminated by a laser of a 
specific wavelength instead of a light source used in wide field microscopy (Figure 
1.10b). The use of a laser to illuminate specific regions of the sample instead of the entire 
sample minimizes out-of-focus background fluorescence and offers higher sensitivity and 
resolution compared to the wide field microscopy
100
. Total internal reflection 
fluorescence (TIRF) microscopy is the ideal method to image cell–matrix interactions. In 
TIRF, cells attached on a transparent surface (e.g., glass slide) are illuminated with a laser 
beam through the transparent surface. The laser beam is positioned to go through the 
solid/liquid interface at an angle that is equal or greater than the critical angle of total 
internal reflection to produce evanescent wave. The evanescent wave penetrates and 
illuminates the sample in a very short depth of approximately 100 nm (Figure 1.10c). 
This small illumination region leads to a high signal-to-noise ratio and highly sensitive 
detection of adhesion structures
101
.   
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1.3.3 Use of Label-Free Whole Cell Assay to Study Cell Adhesion   
 
 
 
Figure 1.11. Schematic of label-free whole cell assay. (A) Electric cell-substrate impedance sensing 
(ECIS). (B) Surface plasmon resonance (SPR).  (Adapted from reference 102)  
 
 
Label-free whole cell assays  measure the integrated cellular response that reflects 
the overall cellular response to the external stimulation
61
. In addition, label-free whole 
cell assays do not need labels that may potentially alter the physiological cellular 
environment for the targets of interest. Current label-free whole cell assays are primarily 
based on impedance, optical, or acoustic sensor technologies, which can detect changes 
in cellular features, such as cell adhesion, cell morphology, cell proliferation, and cell 
death
62-64
. Label-free whole cell assays have the ability to measure responses in real time 
and provide time-dependent profiles of cellular responses. These profiles are able to 
provide information on the kinetics of cellular response. Impedance and optical sensor 
technology will be briefly discussed here and acoustic sensor technology (e.g., quartz 
crystal microbalance) will be discussed in Chapter 2.  
Impedance-based cell monitoring technology was invented by Drs. Ivar Giaever 
and Charles R. Keese in 1984 and is currently known as electric cell-substrate impedance 
sensing (ECIS) (Figure 1.11A)
103
.  The core components of the impedance sensor are two 
electrodes, one small working electrode and one large counter electrode. Live cells in 
21 
 
 
 
medium are grown between the two electrodes and a sinusoidal voltage is applied to the 
sensor to generate electric field between the electrodes
104
. The presence of cells impedes 
on the electric field because the cell membrane can act as an insulating agent. This then 
forces the current to flow between or beneath the cells, which leads to changes in 
impedance. The impedance is a measurement of the changes in the electrical conductivity 
or permeability of the cell layer
105
. Impedance-based measurements have been applied to 
study a wide range of cellular events, including cell adhesion and spreading
106
, cell 
micromotion
107
, cell morphological changes
106
, cell death
108
, and cell signaling
109
. 
Optical sensor technology has been widely used for diverse biological 
applications
60, 104
, including receptor biology
110
, ligand pharmacology
111
, and cell 
adhesion
112, 113
. The one that is most widely used for cell study is surface plasmon 
resonance (SPR). In SPR, a polarized light strikes an electrically conducting surface 
between two media at a specific angle known as the resonance angle (Figure 1.11B). This 
then generates an electron charge density wave also known as plasmon. At the resonance 
angle, the minimal light is reflected back to the detector
62
. When a material binds to the 
sensor surface, this causes the resonance angle to shift, and the shift is in proportion to 
the mass of the material attached to the sensor surface.  
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Chapter 2: Introduction of Quartz Crystal Microbalance (QCM) Technology 
 
 
2.1 Basic Principles of QCM Technology 
The QCM is an acoustic sensing device that is capable of probing the surface 
interaction based on changes in mass and mechanical properties of the material coupled 
to the sensor surface. The QCM has been utilized in chemical
67
,  physical
71
, biological
72, 
73
, and biomedical research
74
. In recent years, the QCM has begun to show its 
effectiveness in cell biology studies with a special focus on cell-surface interactions
114-120
. 
This is because the QCM is not only highly sensitive and easy to use, but more 
importantly label-free and non-invasive, two of the most important factors to the success 
of cell studies. 
 
 
 
Figure 2.1. Schematic diagram of a quartz crystal sensor. (a) Top and bottow views of the sensor. (b) 
Cross-sectional view of the sensor. (Adapted from QSense®, (http://www.biolinscientific.com/q-sense/)) 
 
 
The key component of the QCM sensor system is a thin AT-cut quartz disk of 14 
mm in diameter and less than 0.5 mm in thickness. Two metal electrodes are positioned 
on the top and bottom sides of the quartz disk (Figure 2.1). Quartz crystals are found in 
two main types of cuts, X-cut and AT-cut, and different cut types will produce different 
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piezoelectric responses
121
. The X-cut crystal is cut normal to the x-axis. The main 
problem with this type of crystal is there are large frequency drifts with temperature
122
. In 
1934, Lack et al. were the first to introduce AT-cut crystals
123. The “T” specifies that the 
quartz is a temperature-compensated cut, and the “A” stands for the first of such cuts to 
be discovered. AT-cut crystals are obtained by cutting the quartz crystal at an angle of 
35
o
 from the z-axis
122
 (Figure 2.2). This AT-cut type is used widely in the industry 
because it delivers good performance over a wide temperature range.  
 
 
 
Figure 2.2. Illustration of AT-cut quartz crystal. (Adapted from reference 122) 
 
 
When an oscillating current is applied, the quartz crystal, which is a piezoelectric 
material, undergoes an in-plane shear-mode oscillation
124
. Such oscillation is sensitive to 
the change in mass coupled to the sensor surface, which shifts the resonance frequency of 
the oscillating crystal. In 1959, Sauerbrey showed that the change in resonance frequency 
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is linearly proportional to the change in mass coupled to the surface of the quartz 
crystal
125
,  
                                                            Δ = - Δ n
C
m f
n
                                                    (1) 
where ∆fn is the change in resonance frequency of the oscillating crystal vibrating at the 
nth mode, ∆m is the mass deposited per unit area of crystal surface, and C is the mass 
sensitivity constant of the instrument. For a 5-MHz crystal, C is 17.7 ng/Hz·cm
2
. The 
Sauerbrey equation is valid when the material coupled to the sensor surface is much 
lighter than the mass of the quartz crystal, and the adhered material is rigid and elastic 
and evenly distributed over the sensor surface. When the above criteria are met, the 
resonance frequency of the oscillating crystal is sensitive to the nanogram-scale change 
of mass. Across the disk-shaped sensor crystal, the mass sensitivity follows a Gaussian 
like distribution: the center of the disk has the maximum mass sensitivity and the 
sensitivity decreases exponentially towards the edge of the disk.  
In the early years of the QCM, most studies that were focused on chemical and 
surface modification research were conducted in vacuo and/or gas phase
126
. Later on the 
QCM was adapted to applications in liquid medium, such as biotechnology and 
biosensing. One major drawback encountered in such applications was that the shift of 
resonance frequency no longer obeys the Sauerbrey relationship due to the viscous 
damping of the oscillating crystal by the liquid medium. To assess the damping effect, the 
QCM instrument was reconfigured as quartz crystal microbalance with dissipation 
monitoring (QCM-D) to measure not only the change in frequency ∆f, but also the 
change in energy dissipation factor ∆D of the oscillating sensor crystal124, 127.  The energy 
dissipation factor D is a dimensionless quantity that is defined as, 
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stored
dissipated
E
E
D
2
                       (2) 
where Edissipated is the energy dissipated during one cycle of oscillation and Estored is the 
total energy stored in the oscillating system. ∆D is typically used to quantify the change 
of energy dissipation and can be determined in the QCM-D based on the time-dependent 
decay of the freely oscillating crystal after the rapid excitation
124, 127
.  Some other QCM 
instruments measure the change in energy dissipation in motion resistance (∆R), which is 
equivalent to ∆D measured by the QCM-D128, 129.    
 The QCM technique is considered non-invasive to mammalian cells, because the 
lateral displacement of the surface of the sensor crystal during oscillation rarely exceeds 
1 nm
130
. Secondly, the sensing region is limited to a narrow region between the bottom of 
the cell layer and the sensor surface. This sensing region can be determined based on the 
penetration depth (δ) of the shear wave generated by the oscillating sensor crystal through 
the following: 
                               =
n
η
δ
πρf
                                         (3) 
                 
where η is the viscosity of the liquid, ρ is the density of the liquid, and fn  is the frequency 
of the n
th
 mode of vibration
124
. An estimate of δ can be made by assuming cells have 
similar properties as water. For mode n = 3, the shear wave has a penetration depth of 
approximately 100 to 150 nm from the surface of a 5-MHz sensor disk
131
. This depth 
coincides with the distance between the bottom of the cell layer and the surface of the 
substrate
132
. Therefore the QCM is highly sensitive to the change of cell adhesion while 
much less sensitive to any change above the basal region of the cell
133
.  
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 Taking into account that the cell membrane is an organized system, the viscosity 
of cells compared with water could vary. Bicknese et al. examined the cytoplasmic 
viscosity near the cell plasma membrane and determined the viscosity of the cell plasma 
membrane is 1.1 ± 0.2 cP at 37
o
C compared with 0.70 cP for water at 37
o
C
134
. Use of 
these viscosities in equation 3 to determine the penetration depth gives values that differ 
only by a factor of 1.25. Either way, the sensing region is still within the basal region of 
the cell.    
 
2.2 Detection of Cell-Substrate Adhesion   
 Some of the earliest cell studies were focused on the adhesion of various cell 
types
133, 135-139
. In those studies, the entire cell adhesion process on the QCM sensor 
surface was examined in real time. These experiments demonstrated a correlation 
between the surface coverage with cells and the changes in resonance frequency ∆f of the 
sensor crystal
135, 136, 140
. Such correlation is more qualitative and does not obey the 
Sauerbery equation. This is consistent with the fact that cells behave more like a 
viscoelastic material, not like a rigid mass
133, 137-139
. 
The process of cell attachment also shifts energy dissipation response ∆D or 
motion resistance response ∆R133, 139, 141-145. The ∆D-response has been primarily used as 
a qualitative measurement of mechanical properties of cell adhesion. The exact 
components or mechanical processes that cause the change in energy dissipation still 
remain controversial. Rodahl et al. attributed the energy dissipation to the damping by the 
liquid medium trapped between the cell and the substrate surface, in the cell membrane, 
and in the interior of each cell
141
. Wegner et al. suggested several possible dissipative 
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processes, such as the deposition of ECM, the change in structure and mechanical 
properties of cellular components, including actin cortex and cell membrane
133
. Marx et 
al. proposed that the dissipation is due to the remodeling of actin filaments that are 
intrinsically connected to cell adhesion molecules
143
. Our recent modeling study suggests 
that the rupture of cell-ECM bonds is primarily responsible for the observed energy 
dissipation, whereas either viscous damping by the trapped liquid or viscous slip of the 
stress fibers can also be a major contributor depending on the stage of cell adhesion. A 
comprehensive understanding of the energy dissipation response is essential for the 
development of a theoretical framework needed for QCM-D based cell study. 
To evaluate the cell adhesion, Fredriksson et al. used the ratio of ΔD/Δf to 
quantify the energy loss per unit of attached cell mass and compare the effects of cell 
types and surface coatings on cell adhesion
142
. This ratio, when plotted against time, 
provides information on the kinetics of the cell adhesion process as well as the time-
dependent change in mechanical property of the adhered cell layer.  
 
2.3 Application of the QCM Detection in Other Areas of Cell Study 
2.3.1 Examination of Material Biocompatibility  
Understanding the mechanisms of cell-substrate interactions has provided the 
motivation for the development of biomaterials in medical implants and tissue 
engineering. The most important property of biomaterial is its biocompatibility, which is 
typically evaluated based on how well target cells adhere and grow on the material 
surface. In recent years, the QCM has been used for such evaluation because of its ability 
to monitor the cell adhesion process in a non-invasive and real-time manner
146-149
. 
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Tantalum (Ta) and chromium (Cr) are two medically relevant surfaces found in 
biomedical implants. The QCM was used to compare the adhesion of pre-osteoblastic 
cells on these two surfaces
139
. The results showed larger frequency and energy dissipation 
shifts when cells adhered to the tantalum-coated surface, suggesting that tantalum is more 
biocompatible than chromium. Hydroxyapatite, a surface coating that has been widely 
used for implants, has also been examined with the use of the QCM for its effectiveness 
in cell attachment
146-148
. The ability of evaluating real-time cell-substrate interactions 
with high sensitivity makes the QCM a useful bio-analytical tool to assess the material 
biocompatibility.  
 
2.3.2 Detection of Biomarkers  
Dysregulation of cellular processes are responsible for the development of many 
diseases.  A detailed understanding of these cellular processes and quick determination of 
the abnormality in the processes can provide the information needed for the early 
diagnosis and successful treatment of many human diseases. The QCM sensor system has 
shown the sensitivity and time resolution required for measurement of the signature 
responses of the cell during the cellular processes including growth
150
, apoptosis
34
, 
morphological change
151, 152
, cell cycles
153
, signaling transduction
154, 155
, migration
156
, etc. 
The signature responses in the form of Δf and/or ΔD reveal changes in cell morphology, 
cell mechanics, cell adhesion, etc. and can be utilized for identification of the 
dysregulated cellular processes and serve as potential biomarkers for medical diagnosis.  
 The mechanical properties of cells have been closely linked to the physiological 
state of the cells
157
. For example, malignant cancer cells often appear to be softer than 
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normal cells
158, 159
. Zhou et al. used the QCM to evaluated viscoelastic properties of two 
different cell lines, HMEC (normal breast cells) and MCF-7 (malignant breast cells), 
based on the cell viscoelastic index (CVI=ΔR/Δf), during the adhesion and spreading 
processes
152
. They determined MCF-7 cells were softer than HMEC cells during cell 
adhesion because MCF-7 cells exhibited a CVI that was 2.5-fold lower than HMEC cells.  
Zhang et al. also used the ΔD/Δf ratio to determine that diabetic red blood cells (RBCs) 
appeared stiffer than  normal RBCs when adhering to endothelial cells
160
. Abnormal RBC 
cells have been associated with vascular complications in diseases, such as diabetes, 
sickle cell anemia, and malaria
160
.  
 Expression levels of specific receptors have a prominent influence on the 
physiological state of the cell and can be used as biomarkers of human diseases 
43, 70, 161
. 
Garcia et al. studied the effect of EGFR expression on cell adhesion
162
. The abnormality 
in expression of EGFR can interfere with the regulation of EGFR signaling pathways
163
 
and may lead to the development of epithelial malignancies in humans
164
. Furthermore, 
overexpression of EGFR, which has previously been linked to enhanced cell motility, 
plays a crucial role in tumor invasion and metastasis
163, 165
. The study by Garcia and 
coworkers showed that cells that overexpress EGFR were able to disassemble the focal 
adhesions more rapidly and remain in a low adherent state for a longer period of time 
than cells that express normal levels of EGFR. Their results suggest that EGFR-
overexpressing cells may be in a more favorable state for the initiation and maintenance 
of cell migration. 
The adhesion pattern/strength is also a characteristic of the physiological state of 
the cell. Chronaki et al. used the QCM to examine the difference in adhesion pattern 
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between normal and cancer human thyroid cells on different surfaces, including titanium, 
gold, and fibrinogen-coated gold cancer
166
. Their results indicate that the two types of 
cells demonstrate different adhesion patterns and can be potentially used as a diagnostic 
tool for thyroid cancer. In recent years, the detection of whole cells has shown significant 
importance in clinical diagnosis of cancer and cancer therapy. One of the major 
challenges of such an approach in detection of cancer cells is to find cancer-selective 
probes that are highly specific towards the binding of the targeted cancer cells
167
. Shan et 
al. developed an aptamer-based QCM biosensor
168
 for detection of leukemia cells. The 
aptamer-based QCM sensors were modified with the immobilized aptamer that 
specifically recognizes the leukemia cells. Zhang et al. successfully developed a 
chitosan–folic acid conjugated QCM sensor to detect and capture MCF-7 breast cancer 
cells through the specific binding of folic acid to folate receptors that are overexpressed 
on the MCF-7 cancer cell membrane
169
. Atay and coworkers constructed a QCM sensor 
to detect highly metastatic breast cancer cells with the immobilized transferrin molecules 
on QCM sensor surface
170
. Highly metastatic breast cancer cells are known to express a 
higher level of transferrin receptors compared to less metastatic breast cancer cells
171, 172
. 
The capability of QCM in differentiating metastatic stages of cancers cells can potentially 
be useful for the screening of patient serum or biopsy samples for metastatic breast 
cancer cells.  
 In summary, the QCM is a non-invasive measuring device that can track changes 
of specific cellular functions and/or properties in a real-time manner. Such capability of 
the QCM can be utilized to detect biomarkers for diagnosis and prognosis of human 
diseases. The QCM-based biomarker detection has the advantages over many of the 
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conventional methods, which are expensive and time-consuming, and require high 
expression of protein markers or antibodies present in the test samples
173
. 
 
2.3.3 Evaluation of Cell-Drug Interactions 
The cell-based QCM sensor system has shown the capability in evaluation of the 
cell-drug interactions. Garcia et al. evaluated the effects of selected inhibitors of 
downstream signaling pathways of the EGFR on the EGF-induced de-adhesion of 
engineered MCF-10A cells
174
. The potencies of these inhibitors were determined and 
are correlated well with the values reported in the literature.  Elmlund et al. used the 
QCM to examine the effects of trastuzumab, a humanized anti-HER2 monoclonal 
antibody, on the overexpressed human epidermal growth factor receptor 2 (HER2) of 
SKOV-3 epithelial cancer cells
175
. It has been reported that HER2 receptors are 
overexpressed in many aggressive forms of breast cancers.  
 The QCM has also been used to evaluate the response of tumor cells to 
chemotherapeutics. Braunhut et al. used the QCM to examine responses of human 
mammary epithelial tumor cells to taxanes
143
. They observed the characteristic shifts of 
frequency and motion resistances during the apoptosis of tumor cells. These distinct shift 
patterns can potentially provide an indicator for predicting therapeutic outcome prior to 
treating a patient. Similar cytotoxcity studies have been conducted with gold 
nanoparticles and paclitaxel on HepG2 cells
176
, adriamycin and selenium nanoparticles 
on Bel7402 cells
177
, selenium ferroferric oxide nanoparticles on osteoblast-like MG-63 
cells
178
, derivate of vitamin E α-tocopherol amidomalate on WB F344 and B16F10 
cells
179
, gallic acid and anthocyanins on HT1080. The designing and implementing fast, 
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cost-effective and informative evaluation of cell-drug interactions is a critical step in the 
early stage of the drug discovery process. It is a critical step because it allows for 
effective identification of novel leads in large compound libraries.  Since the QCM 
technique is a highly sensitive method for the evaluation of cell-drug interactions, QCM 
may become a forthcoming approach for the drug screening process. 
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Chapter 3:  Materials and Methods 
 
3.1 Materials 
Table 3.1. Cell lines  
Cell Line Number Source of Cell Line Manufacturer 
A431 (CRL-1555) Human epidermoid carcinoma ATCC (Manassas, VA) 
MCF-10A (CRL-10317) Human mammary epithelial ATCC (Manassas, VA) 
SK-OV-3(HTB-77) Human ovarian adenocarcinoma ATCC (Manassas, VA) 
HEK 001 (CRL-2404) Human epidermal keratinocyte ATCC (Manassas, VA) 
 
 
 
Table 3.2. Cell culture reagents 
Reagent  Manufacturer 
Cholera toxin Sigma-Aldrich (St. Louis, MO) 
Dulbecco’s modified Eagle’s medium Invitrogen (Carlsbad, CA) 
Dulbecco’s modified Eagle’s medium: nutrient 
mix F12 
Invitrogen (Carlsbad, CA) 
Fetal bovine serum Invitrogen (Carlsbad, CA) 
Horse serum Invitrogen (Carlsbad, CA) 
Hydrocortisone Sigma-Aldrich (St. Louis, MO) 
Insulin Sigma-Aldrich (St. Louis, MO) 
Keratinocyte-SFM Invitrogen (Carlsbad, CA) 
RPMI 1640 medium Corning (Manassas, VA) 
20X Phosphate buffered saline (20X PBS) Teknova (Hollister, CA) 
Penicillin/Streptomycin Invitrogen (Carlsbad, CA) 
Trypsin-EDTA Invitrogen (Carlsbad, CA) 
 
 
 
Table 3.3. QCM-D assay reagents 
Reagent  Manufacturer 
Hanks' balanced salt solution (HBSS) Invitrogen (Carlsbad, CA) 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) 
Invitrogen (Carlsbad, CA) 
Dimethyl sulfoxide (DMSO) BDH (London, England) 
Sodium dodecyl sulfate (SDS) J.T Baker (Philipsburg, NJ) 
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Table 3.4. Ligands and modulators 
Ligand/Modulator Manufacturer 
Adenosine triphosphate (ATP) Applichem (Darmstadt, Germany) 
Bradykinin (BK) American Peptide (Sunnyvale, CA) 
Chloera toxin (CTX) Sigma (St. Louis, MO) 
Cytochalasin D (CD) Enzo Life Sciences (Farmingdale,NY) 
Edelfosine Fischer Chemicals (Fair Lawn, NJ) 
Epidermal growth factor (EGF) Peprotech (Rockhill, NJ) 
Epinephirne (Epi) MP Biomedical LLC (Santa Ana, CA) 
Fibronectin (FN) BD Biosciences (San Jose, CA) 
Histamine dihydrochloride (Hist) Alfa Aesar (Ward Hill, MA) 
Isoproterenol hydrochloride (ISO) EMD Bioscience (Darmstadt, Germany) 
L-779450 (Raf kinase inhibitor IV) EMD Bioscience (Darmstadt, Germany) 
LY294002 Cayman Chemical (Ann Arbor, MI) 
Lysophosphatidic acid (LPA) Caymen Chemical (AnnArbor, MI) 
5'-N-Ethylcarboxamidoadenosine (NECA) Tocris Biosciences (Bristol, UK) 
Nicotinic acid (NA) Alfa Aesar (Ward Hill, MA) 
PD158780 EMD Bioscience (Darmstadt, Germany) 
PD98059 Enzo Life Sciences (Farmingdale,NY) 
Pertussis toxin (PTX) EMD Bioscience (Darmstadt, Germany) 
Thrombin (Thr) Fischer Chemicals (Fair Lawn, NJ) 
U0126-EtOH Selleckchem (Houston, TX) 
U73122 1 Cayman Chemical (AnnArbor, MI) 
Wortmannin Enzo Life Sciences (Farmingdale,NY) 
ZSTK474 Selleckchem (Houston, TX) 
 
 
 
Table 3.5. Antibodies 
Antibody Source of Antibody Manufacturer 
Alexafluor 546 Goat Invitrogen (Carlsbad, CA) 
EGFR monoclonal antibody 
mAb 2E9 
Human Santa CruzBiotechnology, 
Inc. (Santa Cruz, CA) 
Monoclonal mouse anti-vinculin Mouse Invitrogen (Carlsbad, CA) 
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Table 3.6. Cell staining reagents  
Reagents Manufacturer 
Ammonium chloride  Amersco (Solon, OH) 
Bovine serum albumin (BSA) EMD Bioscience (Darmstadt, Germany) 
Ethylene glycol tetraacetic acid 
(EGTA) 
EMD Bioscience (Darmstadt, Germany) 
4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) 
J.T Baker (Philipsburg, NJ) 
Magnesium chloride  BDH (London, England) 
Paraformaldehyde (PFA) Electron microscopy sciences, (Hatfield, PA) 
Piperazine-N,N′-bis (PIPES) J.T Baker (Philipsburg, NJ) 
Triton X Amersco (Solon, OH) 
Vectashield  Vector Laboratories (Burlingame, CA) 
 
 
Table 3.7. Instrumentation  
Instrumentation Manufacturer 
Nanoscope IIIA multimode atomic 
force microscope 
Digital Instruments, Inc. (Tonawanda, New 
York) 
Q-Sense Analyzer (QCM-D E4) Biolin Scientific Q-Sense (Stockholm, Sweden) 
Q-Sense open module (QOM 401)  Biolin Scientific Q-Sense (Stockholm, Sweden) 
Zeiss Axioplan 2 microscope system Scientific Imaging Company (Campbell, CA) 
 
 
 
Table 3.8. Software 
Software Description  Manufacturer 
ImageJ software Used to process fluorescence 
images 
National Institutes of Health 
(Bethesda, MD) 
Origin software  Used to graph and analyze 
QCM-D data 
Origin (Northampton, MA) 
Qsoft 401 2.0.0.275 
software 
Used to monitor and record the 
ΔD and Δf   
Biolin Scientific Q-Sense 
(Stockholm, Sweden) 
Qtools software  
(Qsoft 3.0.1.178) 
Used to convert Qsoft data files 
to excel data files 
Biolin Scientific Q-Sense 
(Stockholm, Sweden) 
Slidebook 5.0 
software  
Used to take and process 
fluorescence images  
Intelligent Imaging Innovations 
(Denver, CO) 
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3.2 Solution and Sample Preparation 
3.2.1 Cell Culture Medium 
DMEM growth medium contains the following additives to the DMEM medium: 10 % 
FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. (U/mL is a unit used for 
enzyme activity; 1 U/mL is the amount of enzyme that catalyzes conversion 1 micromole 
of substrate/min.) DMEM/F12 growth medium contains the following additives to the 
DMEM/F12 medium: 5% horse serum, 20 ng/mL EGF, 0.5 μg/mL hydrocortisone, 50 
ng/mL cholera toxin, 10 μg/mL insulin, 100 U/mL penicillin, and 100 μg/mL 
streptomycin. RPMI 1640 growth medium includes the following additives to the RPMI 
1640 medium: 10 % FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. 
Keratinocyte-SFM growth medium contains: 20 ng/mL EGF, 2 mM L-glutamine, 100 
U/mL penicillin, and 100 μg/mL streptomycin. DMEM, DMEM/F12, RMPI 1640 serum 
free growth medium were prepared with the addition of 100 U/mL penicillin and 100 
μg/mL streptomycin to the corresponding media. Keratinocyte-SFM serum free medium 
were prepared with the addition of 2 mM L-glutamine, 100 U/mL penicillin, and 100 
μg/mL streptomycin to the Keratinocyte-SFM medium. 
 
3.2.2 Assay Buffer and Sample Preparation  
1X PBS rinsing buffer was prepared from the dilution of 20X PBS stock in distilled water 
and autoclaved at 121
o
C and 2 x 10
5
 Pa for 20 min. The QCM-D assay buffer (20 mM 
HEPES, pH 7.2) was prepared from the dilution of 100 mM HEPES buffer in HBSS 
buffer. No pH adjustment is needed. 
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3.2.3 Cell Staining Solutions 
1X PHEM buffer was used in cell staining procedures. 1X PHEM buffer contains 60 mM 
PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl2. Concentrated NaOH was added to 
adjust the pH of 1X PHEM buffer to 6.9. Cell fixation solution contains 3 % PFA and 0.1 
% Triton X100 in 1X PHEM buffer. Quenching solution contains 0.25 % ammonium 
chloride in 1X PBS solution. Blocking solution contains 2 % BSA and 0.1 % Triton 
X100 in 1X PBS solution.  
 
3.3 Cell Culture Methods 
Cell culturing was performed under sterile conditions in a bio-safety cabinet. All cell 
lines were seeded in T75 Corning culture flasks and maintained under a humidified 
atmosphere at 37°C and 5 % CO2. Change of the medium took place three times a week 
and subculturing of cells took place once a week. The cells were usually harvested at 90-
95 % confluency. A431 cells were cultured in DMEM medium containing 10 % FBS, 
100 U/mL penicillin, and 100 μg/mL streptomycin. Wild-type MCF-10A cells were 
cultured in DMEM/F12 medium containing 5 % horse serum, 20 ng/mL EGF, 0.5 µg/mL 
hydrocortisone, 50 ng/mL cholera toxin, 10 µg/mL, 100 U/mL penicillin, and 100 μg/mL 
streptomycin. SKOV-3 cell were cultured in in RPMI1640 medium containing 10 % 
FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. HEK001 cells were cultured in 
Keratinocyte-Serum Free medium containing 5 ng/mL EGF, additional 2 mM L-
glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin.  
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3.4 Sensor Preparation 
QCM-D sensors were prepared by washing the sensors with ethanol and water. Then the 
sensors were exposed to UV/ozone for 20 min and UV light in a tissue culture hood for 
another 30 min. Next each sensor with gold surface facing upward was placed in a 12-
well tissue culture plate. The sensor coated with cells was prepared as follows: when cells 
reached 90-95 % confluency, the growth medium was removed and the adhered cells 
were rinsed with PBS buffer twice to remove the residual medium. Next 0.25 % trypsin–
EDTA was added and the cells were allowed to be incubated in the 37°C/5 % CO2 
incubator for 10 min. Once the cells were detached from the bottom of the flask, the 
growth medium was added to quench the trypsin digestion. The detached cells were then 
transferred to a 15-mL centrifuge tube and spun at 1,200 rpm for 4 min. The supernatant 
was aspirated off and replaced with fresh growth medium. The pellet of cells was broken 
up by gently pipetting the cells up and down. The cell density (cell/mL) was determined 
by application of an optical grid to 10 μL of cell suspension on a glass slide, and the 
number of cells in each grid space was counted under the microscope. The volume of 
suspension placed onto freshly prepared QCM-D sensors in a 12-well plate was 
controlled so that the same number of cells was seeded onto each sensor. Once the cells 
were settled down onto each sensor, the 12-well plate was placed in a humidified 
atmosphere at 37°C and 5 % CO2 to allow the cells to adhere to the sensors and grow. 
Upon reaching 90–95 % confluency, the cells were washed with PBS buffer and starved 
in the corresponding serum-free medium for 18 h prior to QCM-D measurements.  
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3.5 QCM-D Measurements 
A Q-sense analyzer (QCM-D E4, Biolin Scientific) was used to record changes in the 
energy dissipation factor (ΔD) and the resonance frequency (Δfn/n) as a function of time 
at third mode of vibration (n=3).  For simplicity, Δf is used to represent Δf3/3. Typically 
at least 10 replicates were done of each experiment described in subsequent chapters, and 
the figures present representative QCM profiles.  
 
3.5.1 Ligand and Pharmacological Modulators Studies  
All measurements were performed on 14-mm diameter gold-deposited, AT-cut sensor 
crystals with a fundamental frequency of 5 MHz (QSX 301). On the day of the QCM-D 
measurement, the cells grown on the sensors were carefully rinsed with assay buffer (20 
mM HEPES in HBSS buffer, pH 7.2). The bottom surface of each sensor where the 
electrical circuitry is located was dabbed dried with a Kimwipe to remove residual buffer. 
Each sensor was mounted in an open module (Q-sense) and surfaces were covered with 
400 μL of the assay buffer. The modules were then mounted onto the QCM-D platform 
and incubated at 37°C until stable baselines were achieved. Then the assay buffer was 
removed from each module, and a pre-warmed solution containing a ligand compound in 
400 µL of the assay buffer was added. Δf and ΔD were monitored and recorded 
simultaneously at 37
o
C for 2 h upon the addition of the ligand compound. For 
experiments involving pre-treatments with pharmacological modulators, the cells were 
incubated with the pretreatment solutions containing the modulators at 37°C for a 
minimum of 40 min prior to the addition of the ligand compound.  
**The results reported in this thesis were from experiments done on gold-surfaced 
40 
 
 
 
crystals, but identical experiments done on silica-surfaced crystals yielded essentially 
identical results (Figure 3.1). 
 
 
 
Figure 3.1. Comparison of real-time QCM-D measurements (at the third mode of vibration) of the EGF-
induced ΔD-responses of MCF10A using gold coated quartz crystal sensors and glass coated quartz crystal 
sensors
155
. 
 
 
3.5.2 Cell Attachment/Cell Adhesion Studies 
The QCM-D sensors were prepared from AT-cut quartz crystals in the form of 14-mm 
discs with a top surface-coating of a 120-nm thick layer of deposited titanium (QSX 310 
Ti, Biolin Scientific). The QCM-D sensors were cleaned with water and ethanol and 
exposed to UV-ozone for 20 minutes. They were then transferred to a tissue culture hood, 
where they were exposed to UV light. Each sensor was then mounted into an open 
module (Biolin Scientific). To each of the four modules was added 600 μL of 
keratinocyte-serum free cell culture media with 20mM HEPES. The modules were 
maintained at 37°C for 50 minutes to achieve stable baselines. Samples of approximately 
75,000 cells in 600 μL of keratinocyte-serum free cell culture media with 20 mM HEPES 
were prepared. Then the keratinocyte-serum free cell culture media in each module was 
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replaced with the prepared cell sample. Δf and ΔD responses were recorded 
simultaneously at 37
o
C for 18-20 h upon the addition of cell samples. Ligands or 
modulators were added at the same time along with the cell samples when needed.  
 
3.5.3 QCM-D Data Analysis 
The dose-response curve was generated by fitting the average amplitudes (± 1 std. dev.) 
of ΔD-responses as a function of specific ligand concentrations with the following 
equation,  
 
where x is the concentration of the ligand. a corresponds to the maximum ∆D-response, 
which can be determined through curve fitting. Amplitude is defined as the difference 
between the experimental value and the control value, each taken at its maximum or 
minimum ΔD-response and varies for each ligand examined. EC50 values were 
determined from the curve fitting with the aid of Origin software (Origin, Northampton, 
MA, USA). The use of the log functional plot or sigmoid plot for this analysis would not 
significantly alter the resulting EC50 values. 
 
3.6 Immunofluorescence Imaging and Quantitation of Focal Adhesion 
3.6.1 Immunofluorescence Sample Preparation   
For immunofluorescence studies, cells were first seeded on coverslips in a 12-well tissue 
culture plate and then allowed to attach and grow in growth medium overnight in a 
humidified atmosphere at 37°C and 5 % CO2. Next day, the cells were starved in serum-
free growth medium for 18 h. The following day, the starved cells were pre-incubated in 
xEC
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D


50
42 
 
 
 
assay buffer (20 mM HEPES in HBSS buffer, pH 7.2) at 37°C for 1 h. After pre-
incubation, the assay buffer was replaced with 1 mL of pre-warmed ligand solution in 
assay buffer. The cells were incubated at 37°C with the ligand solution for various 
lengths of exposure time. Next the cells were fixed and permeabilized using a solution 
containing 0.1 % Triton X-100 and 3 % paraformaldehyde in PHEM buffer (60 mM 
PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH 6.9). After the fixation/ 
permeabilization step, vinculin, a cell adhesion complex protein, was immunostained 
with a combination of a primary monoclonal mouse anti-vinculin antibody (Invitrogen) at 
a concentration of 1:200 in blocking buffer (PBS with 2 % BSA) and a secondary 
Alexafluor 546 goat anti-mouse (Invitrogen) antibody at a concentration of 1:200 in 
staining buffer (PBS with 2 % BSA). After each step, the cells were rinsed thoroughly 
with blocking buffer. Lastly, the coverslip with cells were mounted onto glass slides 
using Vectashield medium with DAPI (Vector Laboratories, Inc., Burlingame, CA).  
 
3.6.2 Fluorescence Imaging  
The cells were examined and imaged with a wide field inverted fluorescence microscope 
Zeiss Axioplan 2 (Carl Zeiss, Thornwood, NY) equipped with a Plan-Apo 63x/1.40 NA 
objective, a deep cooled CCD camera (ORCA-AG; Hamamatsu Photonics). Images were 
taken in the TRITC channel at 50 ms exposures and processed with the use of Slidebook 
5.0 software. 
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3.6.3 Fluorescence Quantitation  
For quantitation of focal adhesion, ImageJ software (http://rsb.infor.nih.gov/ij/) was used. 
For each image a background area, an area of the image with no cells, was first selected 
and then ten randomly selected cells were selected and measured for fluorescence 
intensities. The fluorescence intensity of focal adhesions was determined by subtracting 
the background intensity from the immunostained vinculin fluorescence intensity of each 
selected cell. To determine statistical significance, p-values were determined (student’s t-
test) by comparing the fluorescence intensity between time points. A value of p < 0.05 
was considered statistically significant.   
 
3.7 Fibronectin-Coated Sensors 
3.7.1 Coating Procedure   
Prior to QCM-D experiments, the sensor crystals were cleaned with water and ethanol 
and exposed to UV-ozone for 20 minutes. They were transferred to a tissue culture hood, 
where they were exposed to UV light for a period of time. The sensors were then 
transferred into a 12-well plate and incubated in a solution of 30 µg/mL fibronectin in 
PBS at 37
o
C for 1 h. Then they were rinsed with PBS twice, dried and mounted onto the 
open modules for QCM-D experiments.   
 
3.7.2 Sensor Surface Characterization.  
An AFM (Veeco NanoScope 3D multimode atomic force microscope) was used to 
examine the roughness of surface. 10 μm regions of the sensor surface were scanned at a 
rate of either 1.61 Hz or 4.07 Hz. 
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Chapter 4: Assessing EGF-Induced Cell De-Adhesion Using the Quartz Crystal 
Microbalance with Dissipation Monitoring ** 
 
 
4.1 Introduction  
 
 
 
 
Figure 4.1. The three main downstream pathways of EGFR signaling that are potentially involved in 
regulation of cell de-adhesion of MCF10A cells. The possible targeted sites of pharmacological 
intervention are indicated with the name of each inhibitor. This map was created based on the original 
pathway map from SABiosciences (Valencia, CA)
155
.  
 
 
 
Adhesion to the extracellular matrix (ECM) and to adjacent cells is an essential 
biological process for cell survival, differentiation, and migration during embryonic 
development, adult homeostasis, wound healing, and tumorigenesis
180
. The primary class 
of membrane receptors mediating cell adhesion is integrins. Integrins can simultaneously  
 
** Parts of this chapter are adapted from: 
Chen, J.Y., Shahid, A., Garcia, M.P., Penn, L.S. & Xi, J. Dissipation monitoring for assessing EGF-induced 
changes of cell adhesion. Biosens Bioelectron 38, 375-381 (2012).   
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bind ECM fibrils on the outside of cells and actin filaments (stress fibers) in the inside of 
cells
181
. The clustered integrins form adhesion complexes located across the bottom 
surface of cells known as focal adhesion, which are primarily responsible for cell 
attachment to ECM and substratum. These cell adhesion complexes are mediated by 
multiple signaling pathways including epidermal growth factor receptor (EGFR) 
mediated signaling pathways
182
.  
EGFR is a transmembrane receptor. When activated with the binding of epidermal 
growth factor (EGF), EGFR regulates cell growth, proliferation, motility and 
differentiation through its downstream signaling pathways 
183, 184
 (Figure 4.1), such as the 
mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) 
pathway
185
, the phosphoinositide 3-kinase (PI3K) pathway
49
, and the phospholipase C 
(PLC) pathway
53
. Overexpression and/or mutation of EGFR may lead to dysregulation of 
these downstream signaling pathways and the development of epithelial malignancies 
such as cancers
163, 164
. It is known that EGF stimulation induces cell de-adhesion that 
often results from disassembly of focal adhesions
54, 186
. Cell de-adhesion is the reverse of 
cell adhesion, which leads to a weaker adhesion of adherent cells to the underlying 
substrate
187
 and in part facilitates cell migration by allowing cells to break attachment at 
the rear while they form new attachments at the front
188
. The EGF-induced de-adhesion, 
which is mediated by the downstream signaling pathways of EGFR, is thought to be a 
critical step in normal embryonic development, wound repair, inflammatory response, 
and tumor cell metastasis
189
.  
In this chapter, we used the QCM-D technique to study cell de-adhesion mediated 
by EGFR signaling. Here we monitored the ΔD-response to EGF stimulation of human 
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breast epithelial cells (MCF10A). The observed time-dependent ΔD-response revealed a 
complex process that includes an initial fast cell de-adhesion, a transition, and finally, a 
slow re-adhesion. These aspects of the process were then compared both qualitatively and 
quantitatively with the results of fluorescence imaging. We also examined the role of 
three downstream pathways of EGFR signaling in the mediation of the de-adhesion 
process by assessing the effect of pathway-specific pharmacological intervention on the 
ΔD-responses. All three pathways, the phosphoinositide 3-kinase (PI3K) pathway, the 
mitogen-activated protein kinase/ extracellular signal-regulated kinase (MAPK/ ERK) 
pathway, and the phospholipase C (PLC) pathway, have previously been linked to the 
mediation of cell adhesion and de-adhesion in other cell lines
44, 45
. 
 
4.2 Results  
4.2.1 Establishing the ΔD-Response Induced by EGF 
To assess the EGF-induced cell de-adhesion process, first we used a QCM-D to 
track the short-term, EGF-induced response of confluent monolayers of human epithelial 
breast cells (MCF10A). Figure 4.2A shows the results of a typical QCM-D experiment in 
which both Δf- and ΔD-responses at the third mode of vibration were recorded 
simultaneously for a confluent monolayer of MCF-10A cells to which 10 nM EGF had 
been added at 37°C. This mode of vibration specifically probes the basal area of the cell 
layer, which corresponds to an approximate depth of 100 nm from the surface of the 
sensor
131
. Once the EGF ligand was added to the cells, the ΔD-response curve exhibited a 
sharp upward spike and the Δf-response curve exhibited a sharp downward spike. Both 
spikes were artifacts of the manual pipetting due to the addition of EGF to the cell layer. 
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After the initial spike, the ΔD-response curve shows a rapid decline that continues until 
~40 min. This period is assigned as phase I of the ΔD-response. At ~40 min, the rate of 
the ΔD-response decline begins to decrease until a valley is reached at ~60 min. Then the 
curve displays a slow rise from the valley for the next 15 to 20 min. The transition of 
decreasing ΔD to increasing ΔD is defined as phase II of the ΔD-response. After the 
transition, the ΔD-response curve begins a steady increase for the next 80 min, which is 
assigned as phase III.  
Next we examined the ΔD-response induced by EGF is dose dependent. Figure 
4.2B shows the ΔD-responses at various concentrations of EGF. It is apparent that the 
higher the concentration of EGF, the greater the magnitude of the ΔD-response. The 
dose-dependency was further assessed by fitting the amplitude of the ΔD-response at 60 
min as a function of the EGF concentration (Figure 4.2C). An EC50 value of 1.2 nM if 
used as an approximate measure of binding affinity 
190
 agrees well with Kd-values of 
EGFR obtained by others
191
. As an aside, it should be noted curve in figure 4.2C is not 
sigmoidal, nor is it semi-logarithmic when the values of the ΔD-response are converted to 
the corresponding natural logarithms. Absence of either of these features may surprise 
pharmacokineticists, but the absence is explained by the facts that the concentration range 
used in our experiments was too small to show such features, if they do indeed exist.   
To further confirm the ΔD-response induced the EGF stimulation is mediated 
through the EGFR pathway, a potent inhibitor of EGFR tyrosine kinase, PD158780
192
 
was used to inhibit the EGFR signaling pathway. Figure 4.2D shows that the ΔD-
response was substantially reduced when the cells were pre-treated with a 100 nM 
solution of PD158780 prior to the exposure to 10 nM EGF. All of these results indicate 
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that the ΔD-response is a highly sensitive and specific measure of EGF-induced cellular 
response mediated by EGFR signaling. 
The QCM-D can monitor changes in energy dissipation and changes in resonance 
frequency. Unlike the ΔD-response, the Δf-response showed no dose-dependence (Figure 
4.2E). All of the Δf-response curves exhibited similar changes as a function of time after 
recovering from the initial downward spikes. These curves show slight variation from 
each other and are close to the negative control (0 nM of EGF).  Considering that the Δf-
response measures primarily the change in mass, the results in Figure 4.2E indicate that 
the basal area of the cell layer exhibits a minimal mass change as a result of EGFR 
signaling. Overall, the Δf-response is not as sensitive and specific a measure of EGF-
induced cellular response as its counterpart in ΔD-response, and so further attention will 
be focused only on the ΔD-response. 
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Figure 4.2. Real-time QCM-D measurements (at the third mode of vibration) of the responses of MCF-10A 
cells to EGF at 37°C. (A) The simultaneously recorded ΔD- and Δf- responses as a function of time in the 
presence of 10 nM EGF. Triphasic pattern of the ΔD-response: I, 0 to 40 min; II, 40 to 80 min; III, 80 to 
160 min. (B) The ΔD-responses at the following concentrations: 0, 1, 5, 10, 20, and 40 nM. (C) The 
amplitudes of ΔD-responses at 60 min as a function of EGF concentrations. The data were fit with the 
dose-response function. EC50 = 1.2 nM. (D) The ΔD-response of the cells induced by 10 nM EGF was 
suppressed by 100 nM PD158780, a known inhibitor of EGFR tyrosine kinase. The inhibition is shown by 
the difference in ΔD-response of the cells with and without the pretreatment of PD158780. (E) The Δf-
responses at the following concentrations: 0, 1, 5, 10, 20, and 40 nM
155
. (At least ten replicates were done 
of each experiment.) 
 
 
4.2.2 Correlating the EGF-Induced ΔD-Response with Cell De-Adhesion 
To further verify the link between the ΔD-response and cell adhesion, we visually 
examined EGF-induced changes in number and size of focal adhesions as a function of 
time with the aid of immunostained vinculin within the focal adhesion complex. As 
shown in Figure 4.3A, prior to exposure to EGF, a large number of prominent focal 
adhesions are seen as short bright streaks of vinculin in both the central portions and 
peripheries of the cells. This is a clear indication of strong cell adhesion. When the cells 
were exposed to 10 nM EGF for 30 min, the stained vinculin became fewer in number, 
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smaller in size, and less intense in brightness (Figure 4.3B). These changes are 
characteristic of reduced level of cell adhesion, attributed to EGF-induced disassembly of 
the focal adhesion complexes
54, 186, 193
. A 60-min exposure to EGF further diminished the 
focal adhesions in size and number, as shown in Figure 4.3C. However, a longer 
exposure to EGF of 100 min and 150 min did not cause any further reduction of focal 
adhesions. They showed a slight increase in size and number, suggesting cell re-adhesion 
occurs during the later stages of the EGF exposure (Figure 4.3D). After a 150-min 
exposure to EGF, focal adhesions (Figure 4.3E) became even more noticeable compared 
with that of 100-min treatment, and this is correlated to a continuing re-adhesion. The 
observations made between 60 and 100 min can be interpreted as a period of transition 
from de-adhesion to re-adhesion. To summarize, when exposed to EGF, a monolayer of 
cells exhibits a complex pattern of adhesion that consists of a sequence of de-adhesion (0 
to 60 min), transition (around 60 min), and re-adhesion (60 to 150 min).  
To have a quantitative assessment of the relationship between the ΔD-response 
and the level of cell adhesion, the changes in level of the focal adhesions were 
determined according to the areal density of immunofluorescently stained vinculin at 
each time point. The results of the quantification are summarized in bar graph form in 
Figure 4.3F. The reduction, transition, and restoration of the focal adhesions imply a 
time-dependent change in level of cell adhesion, which matches very well with the 
pattern of the ΔD-response shown in Figure 4.2A. When the quantified 
immunofluorescence data and the ΔD-response are superimposed (Figure 4.3G), there is 
a strong correlation between the two. This quantitative correlation indicates a linear 
relationship between the magnitude of the ΔD-response and the level of cell adhesion. 
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This suggests that the ΔD-response is a specific and quantitative measure of the level of 
cell adhesion. This correlation is further supported by the experimental evidence that the 
EGF-induced ΔD-response was substantially suppressed when cells were pretreated with 
cytochalasin D (Figure 4.3H), an actin-disrupting drug that is known to abolish the cell 
de-adhesion
194
. 
 
 
 
 
Figure 4.3. The correlation between the ΔD-response and the cell adhesion. (A) to (E) show the 
fluorescence images of focal adhesion in a monolayer of cells after various lengths of time of exposure to 
10 nM EGF: (A) 0 min, (B) 30 min, (C) 60 min, (D) 100 min, and  (E) 150 min. The focal adhesion was 
indicated by the immunostained vinculin. An example of focal adhesion given in each of the figures was 
pointed by an arrow. (F) Quantitation of the density of focal adhesion in relative fluorescence unit (RFU) as 
a measure of cell adhesion strength (mean ± SEM; N = 10). (G) A linear proportion is shown between the 
normalized intensity of the ΔD-response and the normalized RFU of focal adhesion. The trend is highly 
significant (p < 0.0001) compared to random data. (H) The ΔD-response of the cells induced by 10 nM 
EGF was suppressed by 1 µM Cytochalasin D, a known inhibitor of actin filament. The inhibition is shown 
by the difference in ΔD-response of the cells with and without the pretreatment of Cytochalasin D
155
. 
 
 
4.2.3 Assessing the Effect of Signaling Pathways on the ΔD-Response  
The PI3K, MAPK/ERK, and PLC pathways are the three known EGFR pathways 
that have been linked to the mediation of cell adhesion and de-adhesion 
44, 45, 50
. To obtain 
insight into how each of these pathways mediates the EGF-induced change in cell 
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adhesion of a monolayer of MCF10A cells, we perturbed each pathway 
pharmacologically by inhibiting the activity of a selected signaling protein in the 
pathway. We then assessed the effect of the pharmacological intervention on the ΔD-
response.  
To probe the MAPK/ERK pathway (Figure 4.1), we treated cells with 1 and 10 
μM of L77945046, a potent cell-permeable inhibitor of Raf kinase, for 30 min prior to 
EGF stimulation. The magnitude of the ΔD-response diminished as the concentration of 
the inhibitor was increased, indicating a dose-dependent suppression of the EGF-induced 
cell de-adhesion (Figure 4.4A). This suggests that the MAPK/ERK pathway is 
responsible for activating the EGF-induced de-adhesion in MCF10A cells. It has been 
previously shown by others the MAPK/ERK signaling pathway is responsible for the 
EGF-induced de-adhesion in fibroblasts through the disassembly of focal adhesion
54
, a 
process involving the cleavage of focal adhesion with the ERK-activated cellular 
protease, calpain
45
.  
To probe the PI3K pathway, we treated cells with LY294002 (Figure 4.1), a 
potent inhibitor of PI3K
195
. The inhibition of the P13K pathway resulted in a dose-
dependent reduction in the magnitude of the ΔD-response of the cells (Figure 4.4B).  This 
suggests that the PI3K pathway, like the MAPK/ERK pathway, is responsible for 
activating EGF-induced cell de-adhesion, most likely through its downstream effectors, 
including small GTPase Rho A, and/or through crosstalk with the MAPK/ERK 
pathway
44
.  
To probe the PLC pathway we treated cells with U73122 (Figure 4.1) a potent 
inhibitor of PLC (an isotype of phospholipase)196. The inhibition of the PLC pathway 
53 
 
 
 
did not reduce, but rather enhanced the ΔD-response in a dose dependent manner (Figure 
4.4C). The inhibition of the PLC pathway suppresses re-adhesion that occurs in phase III 
of the EGF-induced response. The implication is that the EGF-activated PLC pathway is 
the one responsible for increasing cell adhesion, and this implication is consistent with a 
previous report that PLCγ promotes cytoskeleton remodeling important to cell adhesion 
and motility
165
. Overall, all three EGFR pathways contribute collectively to the mediation 
of the EGF-induced cell adhesion. 
 
 
 
Figure 4.4. The assessment of the signaling pathways responsible for regulation of the ΔD-response of the 
cells. (A) The ΔD-response of the cells induced by 10 nM EGF was suppressed by 1 and 10 µM L779450, 
a known inhibitor of Raf kinase. (B) The ΔD-response of the cells induced by 10 nM EGF was suppressed 
by 3 and 10 µM LY294002, a known PI3K inhibitor. (C) The ΔD-response of the cells induced by 10 nM 
EGF was further enhanced by 5 and 8 µM U73122, a known PLC inhibitor
155
. (At least ten replicates were 
done of each experiment.) 
 
 
4.3 Discussion/Conclusions  
In this study, the real-time ΔD-response was demonstrated to be a sensitive, 
specific, and quantitative measure of the change in level of focal adhesions of MCF10A 
cells induced by EGF. Thus, the ΔD-response serves as a reliable indicator of cell 
adhesion. The link between the change in energy dissipation and the change in cell 
adhesion has previously been suggested based on the study of the dynamic, localized 
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mechanical behavior of A431 cells and also the studies of the attachment and detachment 
of several other cell lines
133, 139, 142-144
. All these previous studies had reached the same 
conclusion that an increase in cell attachment results in an increase in energy dissipation 
and a decrease in cell attachment (detachment) causes a decrease in dissipation. Here we 
have characterized the EGF-induced change of cell adhesion at the molecular level by 
assessing the time-dependent changes in local density of vinculin, a sensitive molecular 
marker for cell adhesion. The result of this characterization reveals a complex adhesion 
pattern that begins with rapid de-adhesion, then goes through a transition, and ends with 
slow re-adhesion. Both the timing and the level of adhesion matched well with that of the 
pattern exhibited by the ΔD-response (Figure 4.3G). This led to our finding of the 
dynamic, quantitative correlation between the ΔD-response and the level of cell adhesion.  
In this study, we also demonstrated that the ΔD-response is a far more sensitive 
measure of EGF-induced cell de-adhesion than the Δf-response. The ΔD-response can be 
used to analyze the overall cellular response of cells amplified from the local change of 
cell adhesion through multiple associated dissipative processes. On the other hand, the 
Δf-response measures only the changes of the protein composition of the cell adhesion 
complex and is restricted to the mass change in a small and localized area, which results 
in low detection sensitivity.   
With this highly sensitive approach, we examined the regulation of the EGF-
induced changes in cell adhesion mediated by the PI3K, MAPK/ERK, and PLC 
pathways. We have confirmed that all three pathways are responsible for regulation of 
cell adhesion. The distinct inhibitory profiles are indication that each of these pathways 
has a distinct role at different stages of EGF-induced changes in cell adhesion. When the 
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MAPK/ERK pathway and PI3K pathway were inhibited, phase I (de-adhesion) of the 
ΔD-responses was suppressed, which suggests these two pathways are responsible for the 
cell de-adhesion process in the EGFR signaling (Figures 4.4A and 4.4B). However, the 
re-adhesion (increase in ΔD-response in phase III) was present in both inhibition profiles 
of the MAPK/ERK and the PI3K pathway (Figures 4.4A and 4.4B), which suggest that 
they are not responsible for re-adhesion. Moreover, when the PLC pathway was 
inhibited, phase III did not exhibit an increase in the ΔD-response, indicating the PLC 
pathway is responsible for re-adhesion (Figure 4.4C). Collectively these pathways along 
with others regulate this biological process in a temporally sophisticated manner. 
Systematically dissecting these unique profiles of the ΔD-response will provide insight 
into the coordination of the dynamic network of EGFR signaling. 
In this study, we have demonstrated that the QCM-D technique is capable of 
providing real-time monitoring of changes in dissipation of a layer of EGF-treated cells, 
and is an indicator of changes in cell adhesion. We determined that changes in cell 
adhesion induced by EGF exhibit a complex temporal pattern regulated by several 
downstream pathways of EGFR signaling. Because of its non-invasiveness to mammalian 
cells,
130
 the QCM-D technique is preferable for assessing cell adhesion to techniques that 
requiring invasive forces or non-native dyes or particles. Because cell adhesion is an 
essential connection between other cellular functions, the QCM-D can potentially be 
exploited for fundamental study of cellular processes, such as cell signaling, trafficking, 
and mechanotransduction, as well as for biomedical research on drug and biomarker 
screening. 
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Chapter 5: Using the Dissipation Monitoring Function of the QCM-D for the In 
Vitro Assessment of the Cell-Implant Interaction 
 
 
5.1 Introduction  
 Most amputees currently utilize a stump-socket interface to connect their 
prosthetic limb
197
. Socket prostheses are designed to be securely fastened around the 
residual limb through the use of belts, cuffs or suctions
197, 198
. Even though advancements 
in socket prostheses have greatly improved the mobility and the wearability of prostheses 
for amputees over the years,  there are still many limitations, such as the potential of 
causing irritation of the adjacent soft tissues, difficulty in mounting due to weight 
fluctuations and muscular atrophy, and difficulty in fitting individuals with short residual 
limbs
199
.  
Transcutaneous prosthetic implants have been developed to overcome some of 
these limitations. In the 1960s, Branemark was among the first group of researchers who 
established the use of transcutaneous prostheses in dental and auricular implantology
200
. 
A transcutaneous prosthetic implant is an abutment that penetrates through the soft tissue 
and skin and is directly anchored to the bone. Clinical studies have shown patients with 
transcutaneous prosthetic implant exhibited improvements in mobility and 
osseoperception
201
. Although transcutaneous prosthetic implants show promising benefits 
for amputees, they have a very high failure rate. Besides that they become loosened over 
time, failures of most transcutaneous prosthetic implants are due to marsupilisation, 
avulsion, and infection
199, 200, 202
. The primary reason for these complications could be 
attributed to an insufficient seal between the implant and the soft tissue/skin due to their 
poor attachment to the implant
203
. The success rate of transcutaneous prosthetic implants 
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can be greatly increased by enhancing the adhesion between soft tissue/skin and implant 
to promote wound healing and reduce infection
204
. 
 Cell adhesion is involved in many essential biological processes, including wound 
healing, cell migration, embryonic development, and tumorigenesis
181
. Biochemical 
techniques, such as colorimetric and fluorometric biochemical assays, are able to 
characterize the cell adhesion process through specific cellular events, such as gene 
expression, generation of secondary messengers and/or translocation of labeled targets
66, 
205
. Many of these techniques require labeling agents, which can affect cellular behavior 
and therefore lead to compromised physiological response of cells. In addition, many of 
these techniques require cell lysis and/or fixation steps that lead to cell death. Therefore, 
they are limited to the endpoint detection of cellular processes. Furthermore, biochemical 
techniques do not provide information about mechanical properties of cells induced by a 
cellular process. Mechanical techniques, such as atomic force microscopy
86
, optical 
tweezers
88
 and centrifugation techniques
90
, can provide the mechanical properties of cell 
adhesion; however, these approaches, by applying strong external forces to the cells, can 
affect the behavior and response of the cells. Therefore, the result from these methods 
may be often misleading. In recent years, innovative label-free systems, including 
piezoelectric
130
, optical
206
, electrochemical
140
, impedimetric, thermometric, and magnetic 
sensor systems
207
, have been developed for detection of cellular response
78
. Some of the 
cellular responses that have been used for detection are based on changes in morphology, 
adhesion, proliferation, and cellular movements
207
.  
In recent years, the quartz crystal microbalance (QCM) has become an effective 
tool to study cell-surface interactions in a non-invasive and real-time manner with the 
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focus on cell-substrate interactions
114-120
. Cell-substrate interaction primarily involves the 
surface receptor integrin, which is responsible for conveying a chemical signal into the 
cell that provides information about the cell’s location, environment, and adhesive state. 
Integrin also connects the cytoskeleton of a cell to a surface substrate, which allows the 
cell to modify its morphology in response to environmental stimuli. The QCM technique 
has also been used to study the effects of various ECM proteins, such as fibronectin, 
vitronectin, and laminin, and other coatings, such as gold, tantalum, chromium, 
polystyrene, silicon dioxide, and hydroxyapatite, on the adhesion and spreading of 
various cell types 
146-149
. Furthermore, the QCM has been utilized to monitor the effect of 
the chemical and the morphological properties of the substrate surface on the attachment 
and spreading of cells
142, 179, 208
 
209
.  
In this study, we used the QCM-D to investigate the cell adhesion process of 
human epidermal keratinocytes (HEK001) to the surface coated with titanium, a material 
commonly used for medical implants (e.g., transcutaneous prosthetics). Human epidermal 
keratinocytes were chosen because keratinocyte is the predominant cell type in the 
epidermis, the outermost layer of the skin, and plays an essential role in sealing the soft 
tissue–implant interface210, 211. In this work, we explored the ability of the QCM-D to 
probe the adhesion process of human epidermal keratinocytes and detect the effects of the 
substrate coating and pharmacological treatment on cell adhesion. Our further 
understanding of the adhesion of human epidermal keratinocytes on the implant type of 
surface will provide leads on future development of therapies for enhancing 
osseointegration and minimizing infection caused by the medical implants. 
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5.2 Results/Discussion  
5.2.1 Real-Time Monitoring of Cell Attachment and Spreading 
In this study, our primary aim is to develop a method with the use of the QCM-D 
to probe the cell adhesion process. We hope to find ways to modulate the adhesiveness of 
cells to the substrate surface coated with titanium, a material commonly used for 
transcutaneous prosthetics. The QCM-D experiments conducted in this study utilized the 
open module setup instead of the typical flow module setup used by others
148, 151
. The 
typical flow module setup procedure for cell adhesion experiments begins with rinsing of 
the sensor with fetal bovine serum (FBS)-containing cell medium to saturate the surface 
with FBS and other proteins. Then cells are introduced slowly over the sensor for a 
period of time until they settle down onto the sensor surface. This is followed by a 
constant flow of complete cell medium throughout the rest of the experiment. Westas et 
al. showed that there is a large variation of cell coverage due to the microfluidics of the 
QCM-D
148
. The open module setup procedure also begins incubating the sensor with 
complete cell medium. Next, the cell medium is removed and cells are seeded on the top 
surface of the sensor. The cells are then allowed to settle and attach for the duration of the 
experiment and the entire adhesion process is monitored with the use of the QCM-D. In 
this study the attachment and spreading behaviors of cells were monitored for periods of 
10-20 h to determine long term adhesion behaviors. With the open module setup, both Δf 
and ΔD-responses of the cell adhesion process exhibited sigmoidal profiles similar to 
what others have obtained with the flow modules set-up 
133, 135-139, 151
 (Figure 5.1).  
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Figure 5.1. Simultaneous, real-time recording of ΔD- and Δf- responses (at the third mode of vibration) 
upon the addition of HEK001 cells onto a titanium-coated QCM-D sensor.  
 
 
5.2.2 Comparison of Δf- and ΔD-Responses in Examining Cell Adhesion and 
Coverage 
 The QCM-D measures the change in mass of cells and the change in viscoelastic 
properties of cells in the form of shifts in resonance frequency (Δf) and energy dissipation 
(ΔD), respectively. The amount of cells seeded onto the QCM-D sensor surface dictates 
the corresponding Δf- and ΔD- responses. This phenomenon has previously been shown 
by others
135, 136, 140
. Figures 5.2C-F show images of the adhered cells on the QCM-D 
sensors with starting cell counts of 100k, 75k, 50k, and 25k, respectively. When more 
cells were added, a higher surface coverage by the adhered cells was observed (Table 
5.1). Figure 5.2A shows the ΔD-response of each cell adhesion process with a specific 
starting cell count and the higher the starting cell count, the stronger the ΔD-response. 
The steepest change in each of the ΔD-response profile occurs between 1.5 to 5 h. Such 
increases are likely due to the increase in the number and strength of adhered cells. It has 
been previously demonstrated the ΔD-response has a strong correlation with the level of 
focal adhesions
155, 174
. According to the Sauerbrey equation, the Δf-response of the cell 
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adhesion was expected to be correlated with the mass change of the adhered cells. 
However, the Δf-responses do not exhibit a clear mass-dependency. In fact, some of the 
Δf-responses were almost indistinguishable even though their starting cell counts were 
vastly different (Figure 5.2B). The lack of mass-dependency can be attributed to the fact 
that the cells behave more like viscoelastic material than a rigid mass
133, 137-139
. The 
results of this study indicate that the ΔD-response is a far more sensitive and specific 
measure of cell-substrate adhesion than the Δf-response155. For the remaining 
experiments of this study, the ΔD-response has been used to evaluate the adhesion 
process of HEK001 cells and a cell density of 75k cells used to avoid over-crowding of 
cells on the titanium-coated sensor.       
 
 
  
62 
 
 
 
 
 
Figure 5.2. QCM-D measurements of the adhesion of HEK001 cells onto the titanium-coated QCM-D 
sensors. (A)  The ΔD-responses of the cells seeded in four different starting cell counts: 25k, 50k, 75k, and 
100k. (B) The Δf-response of cells seeded in four different starting cell counts: 25k, 50k, 75k, and 100k. 
(C) – (F) Images of the cells in four different starting cell counts: (C) 100k, (D) 75k, (E) 50k, and (F) 25k 
on the titanium coated QCM-D sensors after 20 h. 
 
 
Table 5.1. Approximate counts of the cells adhered to the sensor surfaces after 20 h.   
Starting count of the 
cells prior to seeding 
Count of 
adhered cells  
100,000 79000 
75,000 65000 
50,000 45000 
25,000 23000 
 
 
 
5.2.3. Identification of the Three Stages of Cell Adhesion   
The process of cell adhesion to a substrate surface is a complex process and 
requires coordination of protein and membrane receptors. In the initial attachment step of 
cell adhesion, a cell settles down on the surface of a substrate and forms a loose contact 
with the substrate. Next the cell begins to flatten and spread its membrane over the 
substrate surface. Lastly, the cell forms adhesion complexes that connect to the substrate 
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with intracellular actin filaments through membrane receptors
31, 212
. The ΔD-response 
shown in Figure 5.3 exhibits a three-phase response profile: phase I, which occurs within 
the first hour, exhibits a sharp increase. Phase II, which occurs between 1 h and 3 h, 
exhibits a slightly less steep increase in ΔD-response. Lastly phase III, which occurs after 
3 h, displays a gradual increase until it reaches a maximum. To verify the three phases of 
the cell adhesion process, live cell images were taken at various time points. At 0.5 h the 
cells were round and very loosely adsorbed, a clear indication of phase I initial 
attachment (Figure 5.4C). At 1.5 h, a small number of the cells were flattened, which is 
an indication of phase II cell spreading. However, the majority of cells were still round 
(Figure 5.4D), which is consistent with the appearance of phase I. This mixed cell 
morphology confirms that 1.5 h is likely a time point when the transition from phase I to 
II occurs. This is also the case for the image at 3 h (Figure 5.4E) where the transition 
from phase II to III occurs with many of the cells still in the phase II appearance. At 6 h, 
the majority of the cells were completely flattened, indicating the formation of focal 
adhesions and the appearance of the phase III (Figure 5.4F). Lastly at 20 h, all of the cells 
appeared in the phase III stage (Figure 5.4G). It is noteworthy that for the last three time 
points, 3 h, 6 h and 20 h, the number of cells adhered on the sensor remains virtually the 
same (Figure 5.4B). However, the ΔD-response continues to rise during this time and is 
nearly doubled between the responses at 3 h and 20 h. This clearly suggests that the 
change in energy dissipation in phase III is due to enhancement of the cells-substrate 
adhesion and not due to the increasing number of cells coming into contact with the 
sensor surface. The enhancement of the cell-sensor adhesion can be attributed to the 
formation of focal adhesion complexes, which increase the adhesion strength between the 
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cells and the sensor surface. The enhancement of cell adhesion also flattens the cells, 
resulting in a morphology that is consistent with those shown by the cells at 6 h and 20 h. 
 
 
 
 
Figure 5.3. The ΔD-response profile of the three sequential stages of adhesion of HEK001 cells on the 
titanium-coated QCM-D sensor. (A) Phase I (0-1 h): initial attachment. (B) Phase II (1-3 h): cell spreading. 
(C) Phase III (> 3 h): cytoskeleton reorganization and formation of focal adhesion. (At least ten replicates 
were done of each experiment.) 
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Figure 5.4. Live cell images at different time points of adhesion of HEK001 cells on the titanium-coated 
QCM-D sensor. (A) The ΔD-response of 75k cells seeded onto the sensor. (B) Numbers of the adhered 
cells and the corresponding QCM-D-responses at various incubation times. (C-G) Images of the adhered 
cells at time points: 0.5 h, 1.5 h, 3 h, 6 h, and 20 h after initial seeding.  
 
5.2.4 Effects of Surface Coating on the Cell Adhesion Process  
The adherence of cells to a biomaterial surface is determined by the material’s 
surface properties. The ability to closely mimic the in vivo environment can potentially 
improve the biocompatibility of the material surface. In recent years, the QCM has been 
used as a tool for the evaluation of real-time cell-surface interactions of biomaterials
146-149
  
because of its ability to monitor the cell adhesion process in a non-invasive and real-time 
manner. When cells adhere to a substrate, cells first excrete a layer of extracellular matrix 
(ECM) proteins that are adsorbed onto the surface. Some of those ECM proteins include 
collagen I and IV, laminin, and fibronectin
213
. There have been studies conducted to 
determine which ECM proteins enhance keratinocyte attachment in vitro. Adam et al. 
studied the effects of the ECM proteins, collagen I and IV, laminin, and fibronectin, on 
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the attachment of keratinocytes onto a plastic surface
214
. Their studies demonstrated that 
fibronectin had the greatest enhancement on the attachment of keratinocytes and the best 
keratinocytes attachment took place between 3-4 h. Similar results were determined by 
Bush et al
215
.  
In this study, we monitored the process of cell adhesion to the sensor with either a 
bare titanium surface or a titanium surface coated with fibronectin. The surface coating 
was characterized with AFM imaging. The bare titanium sensor surface exhibited a 
smooth surface morphology indicated by minimal surface height represented by darker 
coloration (Figure 5.5A). The titanium sensor surface coated with fibronectin showed a 
rougher morphology displayed by a large variation of surface height represented by the 
combination of darker and lighter colored regions (Figure 5.5B). When HEK001 cells 
were adhering to the Ti sensor coated with fibronectin, the resulting ΔD-response showed 
a three-phase pattern that was very similar to the one shown by the Ti sensor without the 
fibronectin coating; however, the magnitude of the ΔD-response from the fibronectin-
coated Ti sensor is significantly higher (Figure 5.6A), which indicates fibronectin coating 
enhances the adhesion of cells onto the Ti-coated surface. This result is verified by the 
cell images that show slightly flatter cell morphology on the fibronectin-coated sensor 
surface compared to the one without the fibronectin coating (Figures 5.6C and D). 
Additionally, the ΔD-response of the fibronectin-coated surface exhibited a shorter phase 
II and more rapid increase during the early stage of phase III compared with the one of 
the bare surface. This result suggests that the fibronectin coating accelerates the 
formation of cell-substrate adhesion, likely by the binding of integrin with the pre-
existing fibronectin.       
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Figure 5.5. Comparison of surface coatings of QCM-D sensors. (A) AFM image of the bare titanium 
surface. (B) AFM image of the titanium surface coated with fibronectin.   
 
 
 
 
Figure 5.6. Comparison of the effect of fibronectin coating on the adhesion of HEK001 cells. (A) The ΔD-
response profiles of adhesion of the cells on the sensor surfaces with and without the fibronectin coating. 
(B) Image of the cells adhered to a bare Ti-coated sensor surface. (C) Image of the cells adhered to a 
fibronectin coated Ti sensor surface.     
              
 
5.2.5 Effects of Epidermal Growth Factor on the Cell Adhesion Process  
Epidermal growth factor (EGF) is known to be able to induce mitogenic and 
motogenic responses in many cell types, including fibroblasts, keratinocytes, and 
epithelial cells
155, 174, 216
, as well as impacting the cell-substratum adhesiveness, 
membrane activity, and/or contractile force generation.
216
 When HEK001 cells were 
treated with 5 ng/mL EGF, the magnitude of the resulting ΔD-response was significantly 
reduced compared with the untreated cells (Figure 5.7A), suggesting a reduction of cell-
68 
 
 
 
substrate adhesion by EGF. This reduction of cell adhesion was confirmed by a slightly 
less flat morphology displayed by the EGF-treated cells (Figures 5.7B and 5.7C).  
Maheshwari et al. have previously demonstrated that EGF is capable of modulating the 
strength of cell-substrate adhesion and allowing the cell to be in a migratory state so it is 
ready for attachment at the front of the cell and detachment at the rear of the cell
216
. Thus, 
EGF may play a critical role in mediating cell migration during wound healing of skin. 
 
 
 
 
Figure 5.7. The effect of epidermal growth factor (EGF) on adhesion of HEK001 cells. (A) The ΔD-
responses of the cells on the fibronectin-coated sensors with or without exposure to 10 nm EGF. (B) Image 
of the cells on a fibronectin-coated Ti sensor surface. (C) Image of the EGF-treated cells on a fibronectin 
coated Ti sensor surface.  
 
 
5.2.6 Effects of Pathway Specific Modulators on the Cell Adhesion Process  
 The ERK/MAPK pathway is one of the principal signaling cascades by which 
cells respond to extracellular and intracellular cues. Abnormal activation of ERK/MAPK 
pathway is a common occurrence in many human cancers. In this study, we examined the 
effects of PD98059 and U0126 on adhesion of HEK001 cells onto the titanium-coated 
sensor surface, respectively (Figures 5.8A1 and 5.8B1). Both modulators are known 
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inhibitors of MAPK kinase 1, a key enzyme in the ERK/MAPK signaling pathway, 
which is responsible for the regulation of cell migration both in vivo and in vitro
217, 218
. 
The ΔD-response of HEK001 cells in the presence of 10 µM PD98059, showed an 
overall increase in magnitude over that of HEK001 cells in the absence of the modulator. 
A similar increase in ΔD-response was also observed with the cells in the presence of 10 
µM U0126. The overall increases in ΔD-responses in the presence of MEK1 inhibitors 
imply that suppressing the ERK/MAPK pathway enhances the adhesiveness of the 
keratinocytes on the titanium surface. The enhanced adhesiveness is confirmed by the 
stronger cell adhesion and higher cell coverage shown in Figure 5.8. Thus, 
pharmacological modulation of the ERK/MAPK pathway could potentially provide an 
effective way to enhance osseointegration and minimize the infection caused by the 
medical implants.  
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Figure 5.8. The effect of ERK/MAPKK pathway-specific modulators on adhesion of HEK001 cells. (A1) 
The ΔD-responses of HEK001 cells adhering onto the titanium-coated sensor surfaces in the presence and 
absence of 10 µM PD98059. Images of HEK001 cells adhered to the titanium-coated sensor surfaces in the 
absence (A2) and presence (A3) of 10 µM PD98059. (B1) The ΔD-responses of HEK001 cells adhering 
onto the titanium-coated sensor surfaces in the presence and absence of 10 µM U0126. (B2) Image of 
HEK001 cells adhered to the titanium-coated sensor surfaces in the absence (B2) and presence (B3) of 10 
μM U0126.  
 
 
The PI3K signaling pathway is responsible for the regulation of cellular survival, 
proliferation, and growth. When PI3K is activated, phospholipids are generated to further 
activate Akt, a serine/threonine kinase and other downstream effectors proteins
219
. In this 
study, we examined the effects of LY294002 and ZSTK474 on adhesion of HEK001 cells 
onto the titanium-coated sensor surfaces, respectively (Figure 5.9). Both modulators are 
known inhibitors of PI3K, a key enzyme in the PI3K signaling pathway
195, 220
, which is 
involved in mediating cell adhesion in conjunction to promoting cell survival and 
proliferation. The ΔD-response of HEK001 cells in the presence of 1 µM LY294002, 
showed an overall increase in magnitude over that of HEK001 cells in the absence of the 
modulator. A similar increase in ΔD-response was also observed with the cells in the 
presence of 250 nM ZSTK474. The overall increases in ΔD-responses in the presence of 
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PI3K inhibitors imply that suppressing the PI3K pathway enhances the adhesiveness of 
the keratinocytes on the titanium surface. The enhanced adhesiveness is confirmed by the 
stronger cell adhesion and higher cell coverage shown in Figure 5.9. Overall the PI3K 
pathway has the effect on the cell adhesion process similar to the ERK/MAPK pathway.  
 
 
 
 
Figure 5.9. The effect of PI3K pathway-specific modulators on adhesion of HEK001 cells. (A1) The ΔD-
responses of HEK001 cells adhering onto the titanium-coated sensor surfaces in the presence and absence 
of 1 µM LY294002. Images of HEK001 cells adhered to the titanium-coated sensor surfaces in the absence 
(A2) and presence (A3) of 1 μM LY294002. (B1) The ΔD-responses of HEK001 cells adhering onto the 
titanium-coated sensor surfaces in the presence and absence of 250 nM ZSTK474. (B2) Image of HEK001 
cells adhered to titanium-coated sensor surfaces in the absence (B2) and presence (B3) of 250 nM 
ZSTK474.  
 
 
The PLC pathway is responsible for the attachment of the cell onto the ECM
221
.  
Crooke et al. compared PLC-γ1-deficient fibroblast cells with normal fibroblast cells and 
showed the PLC-γ1-deficient cells to have decreased cell adhesion, spreading and 
migration
221, 222
.  In this study, we examined the effects of U73122 and edelfosine on the 
adhesion of HEK001 cells onto the titanium-coated sensor surfaces, respectively (Figure 
5.10). Both modulators are known inhibitors of phosphoinositide phospholipase C (PLC), 
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a key enzyme in the PLC signaling pathway
223, 224
. The ΔD-response of HEK001 cells in 
the presence of 10 µM U73122, showed an overall decrease in magnitude compared with 
that of HEK001 cells in the absence of the modulator. A substantial decrease in ΔD-
response was also shown with the cells in the presence of 1 µM edelfosine. The overall 
decrease in the ΔD-response in the presence of PLC inhibitors imply that suppressing the 
PI3K pathway significantly reduces the adhesiveness of the keratinocytes on the titanium 
surface. The reduced adhesiveness is confirmed by the weaker cell adhesion and much 
lower cell coverage shown in Figure 5.10. This study indicates the PLC pathway has a 
significantly negative impact on the attachment of human epidermal keratinocytes onto 
an implant type surface. 
If one reviews Figures 5.8-5.10, one sees that the controls (0.0 μM modulator) are 
nearly identical (vertical scales in the figures are different). The small differences are 
inherent in cell cultures done at different times under identical conditions.   
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Figure 5.10. The effect of PLC pathway-specific modulators on adhesion of HEK001 cells. (A1) The ΔD-
response of HEK001 cells adhering onto the titanium-coated sensor surfaces in the presence and absence of 
10 µM U73122. Image of HEK001 cells adhered to the titanium-coated sensor surfaces in the absence (A2) 
and presence (A3) of 10 μM U73122. (B1) The ΔD-response of HEK001 cells adhering onto the titanium-
coated sensor surfaces in the presence and absence of 1 µM edelfosine. Image of HEK001 cells adhered to 
the titanium-coated sensor surfaces in the absence (B2) and presence (B3) of 1 μM edelfosine. Both 
inhibitors reduced the overall level of the adhesion between HEK001 cells and the titanium surface, 
displayed by the decrease of the ΔD-response. Images show significantly fewer cells adhered to titanium 
sensor surface with PLC pathway modulators.  
 
 
5.3 Conclusions  
From this study, we have demonstrated that the QCM-D is an effective technique 
for detection of the adhesion process of human epidermal keratinocytes under 
physiological conditions. The effectiveness of the QCM-D relies not only on the ability 
for monitoring the cell adhesion process in a real-time and non-invasive manner, but also 
the sensitivity and time resolution for examining the fine details of the time-dependent 
ΔD-response to provide a mechanistic insight into the adhesion process. For example, we 
have established the three-stage adhesion process of human epidermal keratinocytes 
based on the profile of the time-dependent ΔD-response. Also from this study, we have 
further established that the ΔD-response is a far more sensitive and specific measure of 
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cell-substrate adhesion than the Δf-response, in part due to the viscoelastic property of the 
cell.  
We have shown that the adhesion of human epidermal keratinocytes on an 
implant type of surface can be modulated in a variety of ways, such as surface coating 
with fibronectin, growth factor stimulation, or pharmacological modulation. Overall we 
have established the QCM-D as an effective technique to characterize the effectiveness of 
biomaterials for prostheses and to aid in the identification of therapies that are capable of 
enhancing cell adhesion to promote wound healing.  
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Chapter 6:  Assessing GPCR-Mediated Cell Adhesion Using Dissipation 
Monitoring of the QCM-D 
 
 
6.1 Introduction  
G protein-coupled receptors (GPCRs) are a large family of  receptors responsible 
for the transduction of information from the extracellular environment to the intracellular 
environment
225
. GPCRs account for approximately 2-4 % of the human genome and are 
characterized by its seven transmembrane (7TM) domain configuration
226, 227
. When a 
ligand binds to the GPCR, it results in the dissociation of the heterotrimeric G protein 
into active Gα and Gβγ subunits
228. The disassociated α-subunit then couples with a 
specific effector protein to influence a diverse set of downstream signaling cascades
229
. 
The downstream signaling cascade is directly dependent on the α-subunit type (Gs, Gi/o, 
Gq/11, and G12/13)
229
 (Figure 6.1). 
 GPCRs control many physiological functions, such as sensory transduction
230
, 
cell-cell communication
231
, muscle contraction
232
, neurotransmission
233
, immune 
response
234
, and hormonal signaling
235
. The dysfunction of GPCRs contributes to health 
conditions and diseases, such as inflammatory disease
236
, cardiovascular disease
237
, and 
cancer
226
. More than 50 % of the current therapeutics target GPCRs directly or indirectly 
making this family of receptors one of the largest groups of receptors targeted for 
drugs
226, 238
. Two major foci of GPCR research are the development of GPCR screening 
assays and understanding the mechanism of the GPCR receptors.   
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Figure 6.1. The GPCR signaling pathway. This map was created based on the original pathway map from 
SABiosciences (Valencia, CA). 
 
 
 Some stimuli that can activate GPCRs, include proteins, lipids, peptides, 
hormones, small biomolecules, and light
239
. The endogenous ligands are known for about 
20 % of GPCRs and for the remaining GPCRs, the endogenous ligands are unknown. 
These GPCRs with unidentified endogenous ligands are known as “orphan” GPCRs240, 
241
. In this study, we will look at some endogenous ligands and small biomolecules that 
have been shown to activate specific GPCRs. For the activation of specific GPCRs of the 
Gαs pathway, we analyzed the following ligands: epinephrine (Epi)
242, 243
, 5'-N-
Ethylcarboxamidoadenosine (NECA) 
244, 245
, and isoproterenol (ISO)
246, 247
. For the 
activation of specific GPCRs of Gαi pathway, we examined lysophosphatidic acid 
(LPA)
63, 248
 and nicotinic acid (NA)
249, 250
. For the activation of specific GPCRs of Gαq 
pathway, we studied adenosine triphosphate (ATP)
251, 252
, bradykinin (BK)
253, 254
, 
thrombin (Thr) 
255-257
, and histamine (Hist)
258, 259
. 
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 It has been shown ligands can signal through GPCRs via a preferred signaling 
pathway, but can activate other signaling pathways
260
. Crosstalking of multiple pathways 
can potentially have an effect on the binding specificity and efficacy of the ligands. Such 
crosstalk interactions may have a significant impact on the physiological outcomes of the 
receptor and therefore can potentially provide novel targets for therapeutics and provide a 
new perspective on the signaling pathways
261
. Crosstalk can occur at various levels of the 
signaling pathway, it can occur at the receptor level and at the effector/second messenger 
level
260
. At the receptor level, crosstalk can occur through receptor dimerization
262
. A 
ligand can bind at one receptor of the formed receptor dimer, and this will affect the 
ligand binding to the second receptor causing different downstream effects
262
. There is 
also evidence crosstalk can occur when there are multiple conformations of the receptor, 
where the G protein favors a specific conformations and this leads to the activation of 
multiple G protein signaling pathways
149, 263, 264
. Lastly the more conventional signaling 
crosstalk is through downstream activation of effector molecules and the production of 
secondary messengers. Many have studied the crosstalk mediated through Gi pathway’s 
βγ subunit on the activation phospholipase C (PLC) of the Gq pathway
260
. Another well-
established crosstalk is stimulation of adendylyl cyclase of the Gs pathway induced by the 
βγ subunit of the Gi pathway
260
. 
Currently there are many methods for screening the GPCR pathway. Some of 
these methods, include receptor binding, G protein dependent/independent functional, 
real-time fluorescence, and label-free whole cell assays
66
. Receptor binding assay is a 
method for studying and characterizing the interaction between the receptor and the 
ligand
265
. Receptor binding assay is a cell-free method where purified receptors and the 
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radiolabeled ligands are mixed together to allow ligands to bind to the receptors. The 
sample is then washed, filtered, and measured for radioactivity. The receptor binding 
assay is a very high throughput screening method, but it cannot provide information 
about the downstream signaling of the receptor, and therefore it does not provide a 
complete understanding of the signaling mechanism of the receptor
266
. The G protein 
functional assay analyzes the biological responses of a ligand binding to a GPCR by 
quantifying the downstream production concentrations of second messengers and/or 
effectors, such as cAMP, Ca
2+
, IP3, and β-arrestin
267
. Similarly, G protein functional 
assays are very high throughput screening methods, but these assays are very pathway 
specific. The high specificity of these assays makes them not suitable for studying orphan 
GPCRs because their coupled pathways are unknown. In addition, many GPCRs activate 
more than one signaling pathway and since functional assays are very pathway specific, it 
can potentially miss information about the other pathways that are activated due to 
crosstalk or multi-pathway activation
267
. Lastly, these functional assays are not real-time 
assays, and this can result in missed information about the kinetics of cellular responses.  
A more advanced technique for GPCR screening and analysis is real-time 
fluorescence. In real-time fluorescence assays, cell lines that express protein targets 
labeled with auto-fluorescent proteins (e.g., the green fluorescent protein (GFP)) are first 
generated
268
. Then a ligand or compound of interest induces a response in the cells to 
promote protein translocation. The response is then monitored by using an optical 
microscope-based instrument to image or record the fluorescently tagged proteins. Real-
time fluorescence assays can provide information on the kinetics of receptor activation 
and signaling and also on the spatial distribution of the receptors
60
. Fluorescence assays 
79 
 
 
 
allows physical visualization of the mechanisms of GPCR signaling; it allows analysis of 
kinetics of individual steps, and it provides spatial locations of signal proteins within the 
cells
12, 60
. Although optical techniques using fluorescent labels allow more 
comprehensive study of receptor binding and signaling, the presence of fluorescent labels 
can potentially modify the physiological cellular environment of the targeted molecules 
of interest, which may lead to altered and uncertain results.  
 Lastly, label-free whole cell assay is a dynamic and integrated method where the 
overall signal transduction response is measured and not a single transduction pathway
61
. 
Furthermore, these assays are label-free and do not introduce foreign molecules that can 
potentially alter the physiological cellular environment for the targets of interest. Current 
label-free whole cell methods are based on impedance and optical sensor technologies. 
Both of these sensor technologies can detect the changes in cellular features, such as cell 
adhesion, cell morphology, cell proliferation, and cell death
62-64
. GPCR signaling has 
been detected using these technologies and the signals are highly sensitive where it can 
detect endogenous ligand-induced responses
61
. Both technologies have the ability to 
record responses in real-time and provide profiles of the kinetics of cellular responses. In 
addition, these profiles can be quantified to give potency values or EC50 values
61, 66
. The 
combination of the results obtained through label-free whole cell technologies and results 
obtained from traditional cell signaling methods can potentially provide new information 
about cellular pathways and cellular responses mediated through GPCRs.   
 In the work reported here, we used the real-time ΔD-response of QCM-D as a 
way to monitor the cellular response of GPCR activation in human carcinoma A431 cells. 
First, we examined the ΔD-response mediated through the activation of G protein 
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receptors to cell adhesion. Then a series of GPCR ligands that are specific to the Gαq, Gαs, 
and Gαi signaling pathways were examined to provide common ΔD-response features for 
the three well-known and studied of G protein signaling pathways. To determine the 
sensitivity of the ΔD-response to detect GPCR mediated response, the EC50 values were 
obtained for these ligands and were compared to the values determined through 
traditional methods. To confirm that the ΔD-response is mediated through the respective 
GPCR pathway, modulation experiments were performed. Lastly, using modulation 
experiments, we examined signal coordination and crosstalk among multiple signaling 
pathways, and we obtained information on the order of activation in a multiple signaling 
system.  
 
6.2 Results  
6.2.1 Detection of ΔD-Response Mediated Through the Activation of G protein 
Receptors  
 When a ligand binds to a G protein receptor, it can induce a variety of 
intracellular responses. The intracellular response is dependent on the GTP protein bond 
to the receptor. The three main subtypes in which we are mainly interested are Gs-
coupled, Gi-coupled, and Gq-coupled (Figure 6.2). Each subtype of protein can activate 
different downstream effector proteins and in turn produce a different cellular response 
including change in cell adhesion.   
 Epinephrine (Epi) is known to bind the Gs-coupled beta-2 adrenergic receptor 
(A2B) and induces Gαs pathway. The cellular response was recorded as a function of time. 
The Epi-induced ΔD-response profile consists of three phases. The first phase is a sharp 
increase in the ΔD-response to about 3-min (S1 to S2), followed by a 1-minute short and 
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rapid decrease in phase II (S2 to S3), and ending with a gradual level off of the ΔD-
response in phase III (S3 to S4) (Figure 6.2A).  
 Lysophosphatidic acid (LPA) is identified as an agonist for Gi-coupled LPA 
receptor and induces Gαi pathway. The LPA-mediated cellular response profile also 
consists of three phases. The initial phase is a quick and steep increase (I1 to I2) and 
reaching a peak at 6 min (I2), followed by a steep decline below the baseline (ΔD = 0) at 
20 min (I2 to I3) in phase II and ending in a gradual incline in phase III (I3 to I4) (Figure 
6.2B).   
With the adenosine triphosphate (ATP) stimulation, the ΔD-response of the Gq-
coupled P2Y receptor was obtained. ATP-induced response profile consists of three 
phases. The ATP-induced response begins with a fast and steep increase for 10 minutes 
in phase I (Q1 to Q2); secondly, there is a transition phase that includes a short steep 
decrease phase (Q2 to Q3) for 5 minutes and followed by shoulder phase for another 5 
minutes in phase II (Q3 to Q4). Lastly the ATP-induced ΔD-response terminates with a 
gradual level off in phase III (Q4 to Q5) (Figure 6.2C). The three GPCR class agonists 
examined provided three different ΔD-response profiles. The differences in ΔD-response 
profiles can potentially detect downstream signaling of different G- protein classes.  
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Figure 6.2. Real-time QCM-D measurements (at the order of vibrational mode n = 3) of the responses of 
A431 cells to GPCR ligands at 37 °C. (A) The signature ΔD-response of Gs signaling pathway induced by 
100 nM epinephrine (Epi). (B) The signature ΔD-response of Gi signaling pathway induced by 100 nM 
lysophosphatidic acid (LPA). (C) The signature ΔD-response of Gq signaling pathway induced by 20 µM 
adenosine triphosphate (ATP). 
 
 
6.2.2 Correlation of the ΔD-Response Mediated Through the Activation of G protein 
Receptors to Cell Adhesion  
In previous studies, we found that the ΔD-response induced by EGF through the 
EGFR pathways was correlated with de-adhesion and re-adhesion of focal adhesions. The 
decrease in ΔD-response is correlated with weaker cell adhesion and increase in the ΔD-
response associates with stronger cell adhesion. We visually examined GPCR ligand-
induced changes in the number and size of focal adhesions as a function of time with the 
aid of immunostained vinculin. Figure 6.3 A1-A4 shows the images of immunostained 
vinculin of different exposure times of Epi. Our data reveal an increase in the number of 
vinculin spots with increasing exposure time, which is correlated with the Epi-induced 
increase of ΔD-responses over time (Figure 6.3A). Similar experiments were performed 
with LPA (Figure 6.3 B1-B4). After 10 minutes of exposure of LPA, we observed an 
increase in the number of vinculin.  At 30 min and 60 min we observed vinculin levels 
decrease. These results correspond with the rapid increase and rapid decrease observed in 
the LPA-induced ΔD-response. Finally, cells were stained after increasing exposure times 
of ATP (Figure 6.3 C1-C4). We observed the highest levels of vinculin at 10 minutes and 
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weaker levels of vinculin at 30 min and 60 min. These showed similar patterns compared 
to the ΔD-response, where the ATP-induced response increases rapidly within the first 10 
minutes and then gradually decreases. Figures 6.3A-C shows the correlation of the 
normalized dissipation and normalized fluorescence intensities of vinculin with exposure 
of Epi, LPA, and ATP. The comparison between the fluorescence levels of vinculin and 
the ΔD-response for each ligand show when the ΔD-response response increases, the cell 
adhesion increases and when the ΔD-response response decreases, the cell adhesion 
decreases.  
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Figure 6.3. The correlation between the ΔD-response and the cell adhesion. Quantitation of the density of 
focal adhesion in relative fluorescence unit (RFU) as a measure of cell adhesion strength (mean ± SEM; N 
= 10). All correlations determined are highly statistically significant (p < 0.005). (A) A correlation is shown 
between the normalized intensity of the ΔD-response of 100 nM Epi and the normalized RFU of focal 
adhesion induced by 100 nM Epi. (A1) to (A4) show the fluorescence images of focal adhesion by 
immunostained vinculin in a monolayer of cells after various lengths of time of exposure to 100 nM Epi: 0 
min, 10 min, 30 min, 60 min, respectively. (B) A correlation is shown between the normalized intensity of 
the ΔD-response of 100 nM LPA and the normalized RFU of focal adhesion induced by 100 nM LPA. (B1) 
to (B4) show the fluorescence images of focal adhesion in a monolayer of cells after various lengths of time 
of exposure to 100 nM LPA: 0 min, 10 min, 30 min, 60 min, respectively. (C) A correlation is shown 
between the normalized intensity of the ΔD-response of 20 µM ATP and the normalized RFU of focal 
adhesion induced by 20 µM ATP. (C1) to (C4) shows the fluorescence images of focal adhesion by 
immunostained vinculin in a monolayer of cells after various lengths of time of exposure to 20 µM ATP: 0 
min, 10 min, 30 min, and 60 min, respectively.  
 
 
6.2.3 Examination of GPCR-Mediated QCM-D-Response in MCF10A 
 Endogenous G protein coupled receptors can be expressed in various cell lines. 
To determine if the ΔD-response profile of each GPCR subtype is similar in various cell 
lines, a set of GPCR-inducing ligands was studied in MCF10A cells and compared with 
the ΔD-response of A431 cells. NECA was used to induce the Gs-coupled adenosine 
A2A/A2B receptors in MCF10A cells. The ΔD-response profile obtained in MCF10A cells 
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(Figure 6.4A) showed an overall increase in the ΔD-response similar to that of A431 cells 
(Figure 6.4D), but there are differences in the shape of the ΔD-response profile. LPA was 
used to induce LPA1 receptors in MCF10A cells. The ΔD-response profile of MCF10A 
displayed a different profile than that of the LPA-induced ΔD-response in A431 cells. 
The LPA-induced ΔD-response in MCF10A shifted below the control response where the 
LPA-induced ΔD-response in A431 does not (Figure 6.4B and 6.4E). ATP was used to 
induce the P2Y receptors in MCF10A cells. In MCF10A cells the ΔD-response profile 
does not exhibit a gradual phase II, whereas the ΔD-response in A431 cells has a distinct 
shoulder (Figure 6.4C and 6.4F). These differences in the ΔD-response demonstrate the 
ligand-induced response is specific to the cell type. (The possible causes of these 
differences in response are discussed after Figure 8.3 in chapter 8.) These experiments 
demonstrate that the QCM-D is sensitive enough to detect such differences, which can 
potentially be beneficial in differentiating abnormal and normal cellular responses.   
If one reviews Figure 6.4, one sees that the controls (0.0 μM ligand) are very 
similar within each cell type (vertical scales in the figures are different). The small 
differences observed are due to inherent difference in cell cultures done at different times 
under identical conditions.   
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Figure 6.4. Comparison of GPCR ligand-induced QCM-D measurements in MCF10A and A431 cells. (A) 
The ΔD-response of Gs signaling pathway induced by 5 µM NECA in MCF10A. (B) The ΔD-response of 
Gi signaling pathway induced by 10 µM LPA in MCF10A. (C) The ΔD-response of Gq signaling pathway 
induced by 5 µM ATP in MCF10A. (D) The ΔD-response of Gs signaling pathway induced by 1 µM NECA 
in A431. (E) The ΔD-response of Gi signaling pathway induced by 100 nM LPA in A431. (F) The ΔD-
response of Gq signaling pathway induced by 20 µM ATP in A431. 
 
 
6.2.4 Characterization of the ΔD-Response Mediated Through the Activation of G 
protein-Coupled Receptor Subtype  
 To determine specific patterns in the ΔD-response mediated through different G 
protein coupled receptor families, a series of Gs-coupled, Gi-coupled, and Gq-coupled 
inducing ligands were tested. For the response mediated through the Gαs pathway, we 
tested two other ligands, 5'-N-ethylcarboxamidoadenosine (NECA) and isoproterenol 
(ISO). They are known to bind to the adenosine receptor and adrenergic receptor, 
respectively. The ΔD-response of the Gαs pathway-inducing ligands showed a ΔD-
response pattern with a similar initial steep increase followed by an overall increase 
(Figure 6.5).  
 
87 
 
 
 
 
 
Figure 6.5. Comparison of the elevated QCM-D-response induced by Gs stimulated ligands in A431 cells. 
(A) The ΔD-response induced by epinephrine (Epi). (B) The ΔD-response induced by 5’-N-
ethylcaroxamidoadenosine (NECA). (C) The ΔD-response induced by isoproterenol (ISO). (At least ten 
replicates were done of each experiment.) 
 
 
 For the response mediated through the Gαi pathway, we examined nicotinic acid 
(NA) mediated through the HM74A receptor. Nicotinic acid-induced ΔD-response 
showed a quick and steep peak at 6-min (I2), followed by a steep decline below the initial 
starting position at 20-min (I3) and ending in a gradual stabilization (Figure 6.6). The 
ΔD-responses of LPA and NA showed very similar response patterns.  
 
 
 
 
Figure 6.6. Comparison of the steep initial QCM-D-response peak induced by Gi stimulated ligands in 
A431 cells. (A) The ΔD-response induced by lysophosphatidic acid (LPA). (B) The ΔD-response induced 
by nicotinic acid (NA). (At least ten replicates were done of each experiment.) 
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 For examination of the response mediated through the Gαq pathway, we also 
studied bradykinin (BK), thrombin (Thr), and histamine (Hist) through the Gq-coupled 
bradykinin B2 receptor (BDKRB2), protease-activated receptor 1 (PAR1), and histamine 
H1 receptor, respectively. The ΔD-response of these three ligands have similar profile of 
a steep initial increasing phase, followed by a short steep decreasing phase with a 
shoulder phase, and ending with a gradual level-off phase (Figure 6.7).  
 From these studies of different ligands of each different G protein receptor 
subtype, we can establish ligands of the same G protein subtype have similar ΔD-
response pattern. These common ΔD-response features can potentially be used to 
characterize the G protein subtype of orphan GPCRs. The common ΔD-response feature 
shared among Gs ligands occurs in phase III, where there is a gradual increase. The 
common ΔD-response features shared among Gi ligands occur in phase I and II, where 
there is a steep increase and followed by a rapid decrease to baseline levels. The common 
ΔD-response feature determined for the Gq ligands is a quick and steep increase that 
occurs in phase I and a slow and gradual decrease in phases II and III of the ΔD-response. 
These common features due to each G protein subtype may suggest that each pathway 
can induce different cellular response detected by the QCM-D and these common 
features are summarized in Figure 6.8.    
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Figure 6.7. Comparison of the steep initial QCM-D-response peak with shoulder induced by Gq stimulated 
ligands in A431 cells. (A) The ΔD-response induced by adenosine triphosphate (ATP). (B) The ΔD-
response induced by thrombin (Thr). (C) The ΔD-response induced by bradykinin (BK). (D) The ΔD-
response induced by histamine (Hist). (At least ten replicates were done of each experiment.) 
 
 
 
 
Figure 6.8. Illustration of common features in the ΔD-response of each GPCR subtype. 
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6.2.5 Analysis of the Dose Dependence of the ΔD-Response Induced by the G protein 
Receptors 
 Many current methods in screening the GPCR pathway provide quantitative 
values that can be used to compare with other methods. To provide a quantitative 
assessment of the QCM-D-responses of the GPCR ligands, an EC50 value was determined 
for each ligand. EC50 is the concentration of agonist that induces a response halfway 
between the maximum and baseline response of the agonist
269
. The EC50 values can also 
be used as an approximation of the binding affinity of a ligand (Kd)
190
.  
  To determine the EC50 values of the GPCR ligands in this study, the ΔD-
responses were acquired at various concentrations for each ligand. Each ligand showed a 
dose dependent increase in the ΔD-response (Figure 6.9). The magnitude of the ΔD-
response at a specific time point was used to determine the EC50. The chosen time point 
for the magnitude measurements was based on the location of the common feature of the 
ΔD-response that was described in the previous section. For the Gs-inducing ligands, Epi, 
NECA, and ISO, the magnitude of the dose response was taken between 20 to 30 
minutes. For the Gi-inducing ligands, LPA, and NA, the magnitude of the dose response 
was taken between 10 to 15 minutes. For the Gq-inducing ligands, ATP, Thr, BK and 
Hist, the magnitude of the dose response was taken between 8 to 10 minutes. The dose 
response curves were generated and fitted to obtain the EC50 values for each ligand 
(Figure 6.10). The calculated EC50 values determined are listed in Table 6.1 and are 
compared to literature EC50 values others have obtained using current methods in 
screening GPCRs. The EC50 values determined with ΔD-response showed less than 10-
fold difference compared with the EC50 values obtained by others using conventional 
methods and techniques. There have been publications comparing data of optical and 
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impedance sensor technologies to traditional GPCR labeling screening methods and most 
comparisons showed a 10-fold difference in EC50 values
61
. Our comparable EC50 values 
to traditional method values demonstrate the QCM-D is a very sensitive instrument 
compared to other label-free biosensors. The EC50 values determined with the ΔD-
response also showed lower EC50 values compared with those determined by 
conventional methods. One reason could be that the time point selected for determination 
of the EC50 value is the maximum in the real-time and continuous ΔD-response, whereas 
conventional methods take data at discrete time points, typically missing the maximum 
response of the a cell to a ligand by a slight amount. The maximum response comes fairly 
quickly after dosing, and is easy to miss if data are taken at discrete time points; any data 
taken slightly after the actual maximum lead to higher EC50 values.  
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Figure 6.9. ΔD-response vs time for GPCR-induced ligands in A431 cells, showing dose response. (A, B, 
C) Gs-mediated ligands: Epi, NECA, and ISO, respectively. (D, E) Gi-induced ligands: LPA and NA, 
respectively. (F, G, H, I) Gq-mediated ligands: ATP, Thr, BK, and Hist, respectively.  
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Figure 6.10. ΔD-response vs. concentration of GPCR-inducing ligands in A431 cells. (A) ΔD-responses 
determined at 8 min as a function of Epi concentration. (B) ΔD-responses at 10 min as a function of NECA 
concentration. (C) ΔD-responses at 9 min as a function of ISO concentration. (D) ΔD-responses at 6min as 
a function of LPA concentration. (E) ΔD-responses at 6min as a function of NA concentration. (F) ΔD-
responses at 6 min as a function of ATP concentration. (G) ΔD-responses at 8 min as a function of Thr 
concentration. (H) ΔD-responses at 6 min as a function of BK concentration. (I) ΔD-responses at 8 min as a 
function of Hist concentration. The EC50 value is shown on each plot.    
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Table 6.1. Summary of EC50 values determined using the amplitudes of ΔD-responses of each ligand. 
GPCR Ligand 
G- 
Protein 
EC50 
(determined w/ ΔD) 
EC50 
(literature) 
Method of 
Detection 
Epi Gs 36.70 + 3.73 nM 54.96 nM 
270
 cAMP 
NECA Gs 0.48 + 0.16 µM 1.0–1.4 µM 
244, 271
 cAMP 
ISO Gs 12.22 + 4.27 nM 19.8 nM 
270
 cAMP 
LPA Gi 21.49 + 6.52 nM 52 nM (IC50) 
272
 cAMP
 
NA Gi 73.50 + 16.81 nM 67–128 nM (IC50) 
273, 274
 cAMP 
ATP Gq 1.43 + 0.37 µM 1.5–5.8 μM 
275
 Ca
2+
 
Thr Gq 2.62 + 0.50 U/mL 6.0+1.0 U/mL 
257, 276, 277
 Ca
2+
 
BK Gq 4.26 + 1.45 nM 6 nM 
278, 279
 Ca
2+
 
Hist Gq 1.12 + 0.34 µM 1-3 µM 
258, 259
 Ca
2+
 
 
 
 
6.2.6 Confirmation of the GPCR Signaling Pathways Through Modulation Studies  
 To further validate that the GPCR mediated ΔD-responses can be related to 
specific subtype of GPCRs, pathway specific modulators were used to suppress the 
response of each GPCR signaling pathway. These modulation studies help to confirm the 
ΔD-response produced is due a specific GPCR signaling pathway and to provide 
information on signal coordination of multiple pathways.  
 Pertussis toxin (PTX), from Bordetella pertussis, catalyzes the ADP-ribosylation 
of the α subunits of the Gαi/o protein subtype. ADP-ribosylation of the α subunit of the Gi/o 
proteins locks the α subunits into an inactive state and hinders the α subunits to inhibit 
adenylyl cyclase (AC)
280
. This modification of the Gαi/o results in the increased 
accumulation of cAMP and therefore alters pathological response to the Gαi/o agonist. 
Cholera toxin (CTX), from Vibrio cholerae, catalyzes the ADP-ribosylation of the α 
subunit of the Gαs protein subtype using cellular NAD
+ 58
. This modulation locks the α 
subunits  in the active state causing elevated cAMP, and therefore over stimulates and 
masks the responses to Gαs agonists. YM-254890 (YM), from the bacteria 
Chromobacterium sp. QS3666, selectively blocks GDP release from the Gαq protein
281
. 
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This inhibits the mobilization of intracellular calcium ion and transcription mediated 
through serum response element (SRE)-stimulated by receptors coupled to Gαq
282-284
. 
Pertussis toxin, cholera toxin, and YM-254980 pretreatment have been used by others to 
suppress the responses of the Gαi, Gαs, and Gαq signaling pathway, respectively
285
.  
 
For modulator studies of the Gαs pathway, cells were pretreated with CTX (a 
modulator) and then were induced with the Gs ligands. In the Epi-induced and the ISO-
induced ΔD-responses showed a suppression of phase III of the ΔD-responses with CTX 
(Figures 6.11A and 6.11C). In the NECA-induced ΔD-response, there was similar 
suppression of phase III of the ΔD-response with pretreatment of CTX. However, phases 
I and II in the NECA-induced ΔD-responses were not inhibited by the CTX (Figure 
6.11B). From these modulation studies on Gs-inducing ligands, we were able to confirm 
the increase in phase III of the ΔD-response is mediated by the Gαs pathway.  
 
 
 
 
Figure 6.11. ΔD-response vs. time showing the effects of CTX on Gs-inducing ligands in A431 cells. (A) 
250 ng/mL CTX pretreatment on 250 nM Epi-induced ΔD-response. (B) 250 ng/mL CTX pretreatment on 
1 μM NECA-induced ΔD-response. (C) 250 ng/mL CTX pretreatment on 250 nM ISO-induced ΔD-
response. 
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 To modulate the Gαi pathway, cells were exposed to PTX and then stimulated 
with Gi-inducing ligands, LPA and NA. The LPA-induced ΔD-response showed a 
significant reduction of the peak in between phases I and II and little change in phase III 
when modulated with PTX (Figure 6.12A). Comparable effects were established with 
NA, where there was significant peak suppression of the peak between phases I and II 
with PTX pretreatment (Figure 6.12B). These studies confirmed the sharp peak in phase I 
and II of the ΔD-response of the Gi-inducing ligands is mediated through the Gαi 
pathway.  
 
 
 
 
Figure 6.12 ΔD-response vs. time showing the effects of PTX on Gi-inducing ligands in A431 cells. (A) 
250 ng/mL PTX pretreatment on 500 nM LPA-induced ΔD-response. (B) 250 ng/mL PTX pretreatment on 
125 nM NA-induced ΔD-response.  
 
 
Finally, experiments were performed with YM-254890 to inhibit the Gq response 
of the Gq-inducing ligands, ATP, Thr, BK and Hist. The ATP-induced ΔD-response of 
cells pretreated with YM showed a suppression of the peak in between phases I and II. 
However, in phase III of the ATP-induced ΔD-response with YM inhibition showed an 
increase to similar magnitude to the ΔD-response with no pretreatment (Figure 6.13A). 
Pretreatment with YM showed a significant suppression of the entire ΔD-response of the 
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Thr-induced, BK-induced, and Hist-induced ΔD-responses (Figures 6.13B-C). These 
studies confirmed the sharp peak with a gradual decrease is the common ΔD-response 
feature of the Gαq pathway.  
 
 
 
 
Figure 6.13. ΔD-response vs. time showing the effects of PTX on Gq-inducing ligands in A431 cells.  (A) 
300 nM YM pretreatment on 20 μM ATP-induced ΔD-response. (B) 300 nM YM pretreatment on 20 U/mL 
Thr-induced ΔD-response. (C) 300 nM YM pretreatment on 50 nM BK-induced ΔD-response. (D) 300 nM 
YM pretreatment on 15 μM Hist-induced ΔD-response. 
 
 
6.2.7 Analysis of Multiple Pathway Activation via Modulation Studies   
 From the previous modulation studies, the ΔD-response of ATP and NECA 
revealed incomplete inhibition in response to pathway specific modulators. This 
incomplete inhibition of the ΔD-response may be due to activation of multiple GPCR 
pathways. Others have shown that GPCRs can couple to more than one G protein and can 
activate multiple signaling pathways
286
. In these studies, all three pathway modulators 
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were used on each ligand to determine the activation of multiple GPCR signaling 
pathways.  
It has been shown by others that A431 cell expresses Gq/s-coupled P2Y11 
receptors, Gq-coupled P2Y1 (weakly), Gq-coupled P2Y4, and Gq-coupled P2Y6 
287, 288
. It 
has also been shown ATP is a non-specific P2Y agonist and can activate any of the 
receptors expressed in A431 cells
289
. In the ATP-induced ΔD-response pretreated with 
CTX exhibited significant suppression of the phase III, but not the initial peak in phase I 
and II.  This suggests that phase III reflects the activation Gαs pathway, and it is likely 
activated through the P2Y11 receptor. The modulation with PTX did not cause a change to 
the ATP-induced ΔD-response, which confirms that the P2Y subtypes expressed in A431 
do not couple to the Gαi pathway (Figure 6.14A). Lastly, the initial peak in phase I and II 
is the portion of the ΔD-response mediated by the Gαq pathway through a combination of 
the Gq-coupled receptors expressed in A431 cells. This demonstrates that the ΔD-
response induced by ATP in A431 cells is a combination of the cellular response 
mediated through early phase activation of the Gαq pathway and a late phase activation of 
the Gαs signaling pathway.  
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Figure 6.14. Real-time QCM-D measurements of the GPCR modulator responses on Gs-inducing ligands of 
A431 cells. (A) Effects comparison of 250 ng/mL PTX, 250 ng/mL CTX, and 300 nM YM pretreatments 
on 250 nM ATP-induced ΔD-response. (B) Comparison of 250 ng/mL PTX, 250 ng/mL CTX, and 300 nM 
YM pretreatments on 1 μM NECA-induced ΔD-response.  
 
 
It has been shown that A431 cell expresses A2A, A2B, and A1 subtypes of 
adenosine receptors
290
. NECA is a non-specific adenosine agonist and can bind to 
adenosine receptor Gs/q-coupled A2A, Gs-coupled A2B, and Gi-coupled A1 and A3. The 
NECA-induced ΔD-response with PTX and YM pretreatments showed significant 
reduction of the initial peak in phase I and II, but little to no reduction of phase III. These 
results suggest that the initial peak could be due to Gαi and Gαq signaling through the A1 
receptor and A2A receptor, respectively. Phase III of the ΔD-response inhibited by CTX 
suggests that it reflects the response of the Gαs signaling through the A2A receptor and A2B 
receptor. The dissection of the ΔD-response induced by NECA suggests the cellular 
response is mediated through a combination of the Gαs, Gαq, and Gαi signaling pathway in 
A431 cells. The modulator studies provide evidence the ΔD-response can be used to 
dissect signaling pathways and potentially provide information about the signal 
coordination, crosstalk between signaling pathways, and stimulation of multiple 
pathways.  
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6.3 Discussion/Conclusions 
 GPCRs are of great interest because of their large involvement in numerous 
physiological and pathological roles in transducing extracellular signals of a broad range 
of biomolecules, including proteins, peptides, and organic compounds, into intracellular 
effector pathway responses. Due to their large influence on physiological functions, such 
as blood pressure regulation, allergic response, hormonal regulation, and progression of 
cancer, this makes them important targets for a variety of therapeutics
235
. There are more 
than 140 orphan GPCRs, for which the endogenous ligands for these GPCRs remain 
unidentified and their natural functions remain unknown
226
. These orphan GPCRs are a 
great source of potential drug targets. Therefore the development of screening assays for 
GPCR has been a major focus to provide insight on the role and mechanism of these 
GPCRs.  
 This study demonstrates the QCM-D can be a useful label-free, real-time, whole 
cell technique in detecting GPCR-induced cellular responses. The QCM-D allows 
biomolecules to operate in a more native-like and physiological-like state compared to 
traditional biochemical assays. Most traditional biochemical assays utilize non-native 
fluorescent labels to track cell signaling pathways and produce foreign environment for 
the molecule of interest, which may lead to uncertainty in the results. We demonstrated 
the ΔD-response induced by specific G protein coupled receptor ligands is dose sensitive 
and allows for quantification. The EC50 values determined for the ΔD-response induced 
by GPCR ligands have a less than 10-fold difference compared to traditional second 
messenger assays (Table 6.1).  
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 The ΔD-response has been shown to provide sensitive measurements of the 
cellular response induced by specific G-coupled receptor ligands in A431 cells. The 
QCM-D can capture unique real-time ΔD-responses of different G protein coupling 
receptors (Gαs, Gαi, and Gαq). In the present study, each G protein coupling receptor 
subtype, when activated, exhibited common features in the ΔD-response, which can 
therefore be used as a qualitative indicator for differentiating the cellular responses of G 
protein coupling receptors. The common feature of ΔD-response for the Gαs signaling 
cascade is a gradual increase in the third phase of the response. The common ΔD-
response feature of the Gαi signaling is a steep peak in phases I and II. The common ΔD-
response pattern determined for the Gαq-induced signaling is the initial steep peak phase I 
and a gradual decrease in phases II and III (Figure 6.8).  
 Due to the QCM-D’s ability to detect changes in cell adhesion, a cellular process 
induced by many pathways allows for non-specific pathway detection. In traditional 
methods, pathway-specific secondary messengers or effectors, such as cAMP, Ca
2+
, IP3, 
and β-arrestin, are detected and do not provide information about the effects on other 
signaling pathways. On the other hand, the QCM-D allows for an objective detection of 
the GPCR-mediated signaling for the reason that cell adhesion can be mediated through 
multiple pathways and not a single specific G protein-coupled pathway. Many studies 
completed by others show that cell adhesion can be affected through stimulation of 
GPCRs
61
. To further confirm this notion, a correlation between the ΔD-response and 
levels of cell adhesion was sought (Figure 6.3). The correlation shown in Figure 6.3, 
between cell adhesion and the ΔD-response, allows for a better understanding of the 
nature of the ΔD-response and provides fundamental information about the cellular 
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response. From this correlation, we demonstrated that the activation of the Gαs pathway 
by epinephrine and isoproterenol causes an overall increased ΔD-response, which 
suggests an increase in cell adhesion. This observation is in line with reports of other 
research groups stating that cAMP induces integrin-mediated cell adhesion through the 
stimulation Gαs-coupled beta-2 adrenergic receptor
291-293
. Gq protein-coupled receptors, 
when activated, result in PIP2 hydrolysis and Ca
2+
 release from intracellular stores via the 
PLC-IP3 signaling pathway
294
. Findings reported in the literature suggest that calcium 
mobilization regulates cell adhesion
295-297
. We also established that the Gq pathway 
induced by thrombin, bradykinin, and histamine resulted in a steep increase in the ΔD-
response that can be interpreted as a rapid increase in cell adhesion. In our studies the Gi 
pathway induced by LPA and NA caused a rapid increase and subsequently a rapid 
decrease in the ΔD-response, which reflects an initial rapid increase in cell adhesion 
followed by a rapid decrease. Other studies have shown LPA causes cell dispersal of 
epithelial cell colonies
298, 299
. The quick increase and decrease in the ΔD-response can be 
due to stimulation of lamellipodia formation and enhanced migration of the cells 
demonstrated by Yamashita et al
299
.  
 The ΔD-response is an integrated response to the cellular response mediated 
through the GPCR pathway. The QCM-D can display the overall cellular response of 
multiple downstream cellular events, unlike many traditional second messenger assays 
that can only quantify specific second messengers, which allows for only partial display 
of the cellular events of a cellular response. The modulation studies revealed multiple 
signaling pathway activation mediated through multiple receptor subtypes of ATP and 
NECA. The deconvolution of ATP-induced and NECA-induced ΔD-responses facilitated 
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the identification of signal coordination in multiple signaling pathways. With the 
combination of the appropriate pharmacological modulators or gene-silencing techniques, 
the QCM-D readout induced by G protein specific ligands can provide novel insight in 
the dynamics of cell signaling. The integrated ΔD-response allows for detections of 
subtle changes that traditional methods cannot detect. In this study, we have successfully 
separated the signaling pathways with the use of modulators, such as PTX, CTX and YM.  
 In summary, the QCM-D technique has been demonstrated to be a potentially 
useful label-free and real-time detection of the GPCR-induced cellular responses. The 
ΔD-response induced by G protein specific ligand can provide comparable quantitative 
results to conventional biochemical methods. The QCM-D allows for non-specific 
pathway detection through the detection of changes in cell adhesion. In addition, the 
time-resolved detection of the QCM-D provides insight on the kinetics of the GPCR 
signaling pathway. Lastly, with the appropriate modulators the ΔD-response can be 
deconvoluted to give insight on signaling dynamics, such as multiple pathway stimulation 
and pathway crosstalk. The QCM-D can potentially provide insight on the role and the 
mechanism of known GPCRs and orphan GPCRs. Lastly the QCM-D can potentially be a 
useful platform in screening novel drug targets.   
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Chapter 7: Real-Time Detection of Cellular Response Mediated by Distinct 
Subclasses of Epidermal Growth Factor Receptors**  
 
 
7.1 Introduction 
Epidermal growth factor receptor regulates cell growth, proliferation, motility, 
and differentiation through its downstream signaling pathways
183, 184
. Ligand binding to 
the extracellular domain of EGFR induces receptor dimerization, activates its kinase 
domain to induce its downstream signaling cascades
300
. Ligand binding studies with the 
use of radiolabeled EGF, the natural ligand of EGFR, suggest that there are two 
subclasses of EGFR
301, 302
: high-affinity EGFR, which exhibits Kd-values of a few nM or 
less, and low-affinity EGFR, which exhibits Kd-values of 10 nM or above.  High-affinity 
EGFR accounts for less than 10 % of the total EGFR; however, it is the subclass that is 
most responsible for the regulation of cell growth, proliferation, motility, and 
differentiation
183, 184
. In contrast, low-affinity EGFR controls Ca
2+
 influx and fluid-phase 
pinocytosis
303
, but contributes little to the regulation of cell growth, proliferation, 
motility, and differentiation. It has been originally suggested by Macdonald and Pike that 
the two subclasses of EGFR arise from negative cooperativity
304
.  A ligand binds and 
forms an asymmetric EGFR dimer in which only one binding site is occupied
305, 306
. The 
unoccupied site in this dimer is structurally restrained and leads to a reduced affinity for 
binding of the second ligand
305, 306
. 
  
** Parts of this chapter are adapted from:  
Chen, J.Y., Li, M., Penn, L.S. & Xi, J. Real-Time and Label-Free Detection of Cellular Response to 
Signaling Mediated by Distinct Subclasses of Epidermal Growth Factor Receptors. Anal. Chem. 83, 3141-
3146 (2011). 
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It is known that an abnormal EGFR signaling can induce uncontrolled cell growth 
and a malignant phenotype, such as tumors
307
. In fact, EGFR is highly expressed in a 
variety of human tumors, including head and neck squamous cell cancer, colorectal 
cancer, non-small cell lung cancer, and breast cancer
43
. Because of the critical role of 
high-affinity EGFR in regulation of cell growth, proliferation, motility, and 
differentiation, the extent of cell signaling mediated by high-affinity EGFR can therefore 
be very informative for assessing the role of EGFR in cancer development and cancer 
diagnosis
308
. This requires a detection system that is capable of tracking cellular 
responses specifically to high-affinity EGFR signaling. 
This chapter describes a QCM-D-based approach that specifically assesses the 
individual cellular response of both high-affinity and low-affinity EGFR signaling. With 
this approach, we were able to distinguish and detect cellular responses mediated by 
high-affinity and low-affinity EGFR signaling. Various real-time and label-free sensor 
technologies have been developed to examine EGFR-mediated cell signaling
309, 310
. 
However, none of those technologies has been able to simultaneously detect the 
individual responses mediated by each of these two subclasses of EGFR and distinguish 
the cell signaling mediated by high-affinity EGFR from that mediated by low-affinity 
EGFR.  
 
7.2 Results/Discussion  
7.2.1 Establishing the EGF-Induced ΔD- and Δf- Responses  
In the present study, QCM-D was used to monitor the short-term, EGF-induced 
response of a confluent monolayer of human carcinoma A431 cells. Figure 7.1 shows 
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ΔD- and Δf- responses of the cells as a function of time under three different sets of 
experimental conditions. Figure 7.1A shows the effect of 10 nM EGF on the ΔD-response 
of the cells. The cells treated with EGF or without EGF (buffer) show an initial sharp 
increase in ΔD (peak DM), which is due to mechanical perturbation of the cells by the 
transfer of liquid by pipetting. After an initial rise, a rapid decrease in ΔD-response is 
shown by both cell samples. However, the EGF-treated cells exhibited a much greater 
decrease in ΔD-response than the buffer-treated cells did. This difference represents the 
EGF-induced ΔD-response of the cells. The observed large decrease in ΔD-response of 
the EGF-treated cells indicates a decrease in adhesion of the cell monolayer on the sensor 
surface. This is consistent with the known stiffening and rounding of A431 cells in 
response to the EGF treatment
311
. The lowest value of ΔD-response was reached at about 
50 min (at dotted line H), which agrees well with previous observations that A431 cells 
develop the most extreme rounding around 45 min
312
. The Δf-responses of the cells from 
the same experiment are shown in Figure 7.1B. The initial response of both the EGF-
treated and buffer-treated cells was a sharp decrease (peak fM), resulting from the above-
mentioned mechanical perturbation. After this, the Δf-response of the buffer-treated cells 
increased and leveled off at a constant value, while the Δf-response of the EGF-treated 
cells continued to rise to produce peak L. Thus peak L represents the EGF-induced Δf-
response of the cells. The increase in Δf-response shown by the rising of peak L reflects a 
decrease in mass, which could arise from the transport of ions or liquid medium out of 
the shallow pockets underneath of the cells into the cytoplasm
114
.  
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Figure 7.1. ΔD- and Δf- responses vs. time for A431 cells exposed to EGF. (A) ΔD-response in the 
presence and absence of 10 nM EGF. Peak DM is indicated by the arrow. Minima in the ΔD-responses are 
indicated by dotted line H. (B) Δf-response in the presence and absence of 10 nM EGF. Peak L and peak 
fM are indicated by arrows
154
. (At least ten replicates were done of each experiment.) 
 
 
7.2.2 Validation of the EGF-Induced ΔD- and Δf- Responses  
Next, we conducted an experiment to determine if both the EGF-induced ΔD- and 
Δf- responses observed were truly the cellular responses induced by EGFR-mediated cell 
signaling. Figures 7.2A and 7.2B show the results for the cells exposed to 10 nM EGF 
pretreated and not pretreated with PD158780, a potent inhibitor of EGFR tyrosine kinase 
which initiates all the downstream signaling pathways of EGFR
192
. The cells without the 
pretreatment showed the expected decrease in ΔD-response (Figure 7.2A) and the 
expected appearance of peak L (Figure 7.2B). The pretreatment with the inhibitor 
suppressed the decrease in ΔD-response (Figure 7.2A) and suppressed the peak L in the 
Δf-response (Figure 7.2B). The results of this experiment showed that EGFR tyrosine 
kinase is responsible for the large decrease in the ΔD-response observed in Figure 7.2A 
and also for peak L in the Δf-response in Figure 7.2B. Thus the ΔD- and Δf- responses 
observed were due to EGFR-mediated cell signaling.  
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Figure 7.2. ΔD- and Δf-  responses vs. time showing the effect of inhibitor on  A431 cells exposed to EGF. 
(A) The ΔD-response of the cells pretreated with EGFR tyrosine kinase inhibitor, PD158780, showing 
suppression of EGF-induced response. (B) The Δf-response (peak L) of the cells pretreated with EGFR 
tyrosine kinase inhibitor, PD158780, showing suppression of EGF-induced response
154
. 
 
 
7.2.3 Distinguishing of Responses Mediated by High-Affinity and Low-Affinity 
EGFR 
The third experiment was done to determine which subclass of EGFR, the low-
affinity or the high-affinity, was responsible for ΔD- and Δf- responses to EGF observed 
in Figures 7.1A and 7.1B. To determine this, we used EGFR monoclonal antibody mAb 
2E9 (333 nM), an antibody that is known to block the cell signaling mediated by low-
affinity EGFR, but not to affect high-affinity EGFR signaling
303
. Figure 7.3A shows that 
the cells with and without pretreatment gave nearly identical decreases in the ΔD-
response. Since the antibody had no effect on the ΔD-response of the cells, the ΔD-
response is therefore due to cell signaling mediated by high-affinity EGFR alone. 
However, the Δf-response of the cells pretreated with the antibody shows that peak L was 
nearly abolished by the antibody pretreatment (Figure 7.3B), leading to the conclusion 
that peak L reflects the cellular response to low-affinity EGFR signaling. 
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Figure 7.3. ΔD- and Δf-  responses vs. time showing the effects antibody on A431 cells to exposed to EGF. 
(A) The ΔD-response of the cells pretreated with EGFR monoclonal antibody mAb 2E9, showing no 
suppression of EGF-induced response. (B) The Δf-response (peak L) of the cells pretreated with mAb 2E9, 
showing a significant suppression of EGF-induced response
154
. 
 
 
7.2.4 Validation of Responses Mediated by High-Affinity and Low-Affinity EGFR  
 To further verify the specificity of the QCM-D signal toward the individual 
subclass of EGFR, the dose-response of EGF was examined. As shown in Figures 7.4A 
and 7.4B, the higher the concentrations of EGF, the greater the amplitudes of the ΔD-
response at dotted line H and Δf-response at peak L, respectively. From the dose-response 
curves (normalized amplitudes of QCM-D signals vs. EGF concentrations) shown in 
Figures 7.4C and 7.4D, the EC50 values were determined to be 2.1 nM for the high-
affinity EGFR (Figure 7.4C) and 39 nM for the low-affinity EGFR (Figure 7.4D). If the 
EC50 values are used as approximate measures of binding affinity
190
, our values for high-
affinity and low-affinity EGFRs are consistent with Kd-values obtained by others. 
Overall, the results of our dose-response study further validate that the QCM-D signals, 
ΔD and Δf, are specific for the high-affinity and low-affinity EGFR, respectively.  
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Figure 7.4. Dose-dependent, EGF-induced responses of A431 cells. (A) Dose-dependent ΔD-responses 
versus time. (B) Dose-dependent Δf-responses versus time. (C) The amplitudes of ΔD-responses at dotted 
line H, average ±1 std deviation of at least ten replicate experiments, as a function of EGF concentration. 
(D) The amplitudes of Δf-responses at peak L, average ±1 std deviation of at least three replicate 
experiments, as a function of EGF concentration
154
.  
 
 
7.2.5 The Identification of EGF-Induced Cellular Processes Responsible for ΔD- and 
Δf- Responses  
To verify whether the ΔD-response is mediated through high-affinity EGFR, we 
examined the remodeling of the cytoskeleton, a process that is integral to high-affinity 
EGFR cell signaling. Cytochalasin D (CD), a potent, cell-permeable inhibitor of actin 
polymerization was used. CD is capable of attenuating the remodeling of the 
cytoskeleton
313
. In Figure 7.5A, pretreatment with CD significantly suppressed the ΔD-
response of the cells to EGF, confirming that cytoskeleton remodeling is the major cause 
of the ΔD-response to EGF. This is similar to the findings of Heitmann and coworkers’ 
that a change in the cytoskeleton is a major contributor to the dissipation-related QCM 
response of cells
114
.  
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Lastly we wanted to determine the specific cellular response responsible for peak 
L in the Δf-response. It has been determined by others that the activation of low-affinity 
EGFR in A431 cells induces Ca
2+
 influx and/or fluid-phase pinocytosis
303
.  The increase 
in Δf is indicative of a decrease in mass within the sensing volume. This suggests that this 
loss of mass could be due to the transport of extracellular ions and/or liquid medium from 
underneath the cell layer into the cytoplasm above. To verify if either of these processes 
is responsible for peak L, we measured the EGF-induced response of the cells pretreated 
with 3 mM of EGTA (ethylene glycol tetraacetic acid). EGTA, a divalent ion chelator,  
blocks calcium influx by trapping Ca
2+
 and preventing its entry into cells
314, 315
. Figure 
7.5B shows that the presence of 3 mM of EGTA significantly suppressed peak L, which 
confirms that the EGF-induced Ca
2+
 influx indeed gives rise to peak L.  
 
 
 
Figure 7.5. The identification of EGF-induced cellular processes that are primarily responsible for ΔD- and 
Δf- responses. (A) ΔD-response was suppressed substantially for the cells pretreated with an inhibitor of 
actin polymerization, cytochalasin D. (B) Δf-response at peak L was almost abolished for the cells 
pretreated with a calcium chelator, EGTA; peak L of the EGTA treated cells is only 6 Hz while that of the 
control (with no EGTA pretreatment) is 42 Hz
154
.   
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7.3 Conclusions  
In conclusion, QCM-D provides a novel approach for monitoring the early 
responses of cells to EGFR-mediated signaling by real-time tracking of changes in the 
energy dissipation and resonance frequency responses of cells. Our study revealed that 
the ΔD-response is associated with the remodeling of the cytoskeleton and represents the 
cellular response to signaling mediated by high-affinity EGFR. The Δf-response is 
associated with the calcium influx and represents the cellular response to signaling 
mediated by low-affinity EGFR. The unique capability of QCM-D can be further 
exploited to investigate the role of activated, high-affinity EGFR in cancer development 
and can potentially complement the existing approaches for biomarker detection and 
prognosis of cancer. 
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Chapter 8:  Detection of Cancer Cell Signaling Biomarkers with the Quartz 
Crystal Microbalance with Dissipation Monitoring 
 
 
8.1 Introduction 
 Ovarian cancer is one of the four major gynecological cancers, and the survival 
rate for ovarian cancer patients is the poorest
316
. The five-year relative survival rate is 44 
% for all stages of ovarian cancer patients
317
. The main reason for such a poor survival 
rate is due to the lack of an effective method for early detection since all of ovarian 
carcinomas are often composed of a variety of histopathological features that exhibit 
distinct biological behaviors
318, 319
. Ovarian cancer is a heterogeneous disease where the 
expressed mutations and/or gene amplifications occur in multiple signaling pathways and 
varies across population of patients
68
. Thus ovarian cancer has not been linked to one 
specific defect in any single protein or signaling pathway. However, two signaling 
pathways have been explicitly studied in mediating the initiation and progression of 
ovarian carcinomas: they are the downstream pathways mediated through epidermal 
growth factor receptor (EGFR)
320, 321
 and lysophophatidic acid (LPA) G protein coupled 
receptor
322, 323
.  
 The EGFR signaling pathway regulates cell growth, proliferation, motility and 
differentiation through downstream signaling cascades of the MAPK pathway, the PI3K 
pathway and the PLCγ pathway324. An abnormal level of EGFR has been reported to be 
present in between 33 % and 75 % of ovarian cancers and has been shown as an 
important factor in both the growth and the progression of ovarian cancer
325, 326
. Due to 
its importance in cancer development, approaches of blocking the activation of EGFR, 
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including receptor-specific inhibitors and anti-EGFR monoclonal antibodies, have been 
developed
41, 326
.  
 Another well-studied factor linked to ovarian cancer is LPA, an autocrine growth 
signal produced from ovarian cancer cells
327
. Studies have shown LPA accumulates at 
abnormally high micromolar concentrations in malignant ascites
328, 329
. LPA affects many 
cellular functions, such as cell proliferation, cytoskeletal reorganization, cell 
survival/apoptosis, cell adhesion/migration, and ion transport, through the activation of 
the Gi, Gq, and G12/13 subfamilies of the G protein
330
. Recent studies have demonstrated 
that LPA can transactivate EGFR through protein kinase C (PKC) and matrix 
metalloproteinase (MMP) activation
68
 and affect cell growth through the PI3K 
pathway
330
.  
 There have been reports demonstrating thrombin
331
 and histamine
332
 to be over 
expressed in ovarian cancer.  Thrombin interacts with specific G protein-coupled protease 
activated receptors (PARs) and mediates the coagulation cascade
331
. It has been shown 
that cancer coagulation factors play a role in the progression and metastasis of cancer 
through a number of growth factors, cytokines and extracellular matrix (ECM) 
proteins
333
. Histamine has been shown to modulate proliferation of many normal and 
malignant tissues through the G protein-coupled histamine receptors. High concentrations 
of histamine have been found in melanoma, colon, breast, and ovarian cancers
334
. The 
association of histamine to malignant tumors remains controversial, but some studies 
have shown that histamine is an important paracrine and autocrine regulator of cell 
growth of tumor cells
335, 336
. To improve survival rate amongst ovarian cancer patients, a 
sensitive assay platform for detection of those potential biomarkers, such as EGFR, LPA, 
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thrombin, and histamine, could be an effective approach for early detection of the 
disease.  
Biomarkers play an important role in disease detection and treatment. There are a 
variety of biomolecules that are considered biomarkers, including antigens, DNA, 
mRNA, and enzymes
337
. The detection of the biomarkers in body fluids, such as blood 
and urine, is a powerful medical tool for early diagnosis and treatment of diseases. Early 
detection of biomarkers is very important in the case of cancer, cardiovascular disorders, 
and other pathological conditions
337
. However at early stages of disease, biomarkers are 
often present in very low concentration making them troublesome to detect
338
. 
Additionally, body fluid samples are a mixture of various proteins, which can make 
specific biomarkers even more difficult to identify. There are many biomarker detection 
methods that have been developed, including enzyme-linked immunosorbent assay 
(ELISA)
339
, gel electrophoresis
340
, mass-sensing bio-optical compact disc (BioCD) 
protein array
341
, colorimetric assay
342
, electrochemical assay
343
, and fluorescence 
methods
344
. Many of these methods are based on the conventional immunoassays where 
antibodies are functionalized on a solid support for target protein capture. Among many 
of these technologies, a common problem is these assays allow for nonspecific adsorption 
of non-target proteins, which can provide inaccurate results. Therefore, the current 
biomarker detection methods lack specificity, accuracy and sensitivity needed for clinical 
application
337
.  
 The QCM-D has shown its capabilities in monitoring the process of cell adhesion 
and detecting cellular responses to ligands and drugs
155, 174
. In recent years, the QCM has 
found its niche in biomarker detection because of its unique capability of providing the 
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functional readout of cells that undergo processes, including signaling transduction
154, 155, 
345
, growth
150, 346, 347
, apoptosis
34
, exocytoses
348
, migration
156
, morphological change
151, 
152
, cell cycles
153
, etc. Such information is indicative of the physiological state of cells 
under normal or pathological conditions and has the potential for applications in 
diagnosis and prognosis of human diseases. 
 In this work, we used the QCM-D to probe the response of ovarian carcinoma 
(SKOV-3) cells to biomolecules, such as EGF, LPA, thrombin, and histamine. These 
molecules have been identified as crucial players in the progression of ovarian cancer. 
The main focus of the study was to determine the sensitivity of this cell-based platform 
for detection of these molecules. We also examined the pharmacological effects of 
LY294002 and wortmannin on the EGF-induced response of SKOV-3 cells. These 
studies will provide evidence that the QCM-D can potentially be a useful analytical tool 
in examining disease progression and evaluating responsiveness to drug therapies.   
 
8.2 Results  
 Membrane-bound proteins or surface receptors comprise about a third of all 
cellular proteins and are highly important in signal transductions. Receptors are the basis 
of signal transduction due to their location, and they are responsible for converting an 
extracellular signal into an intracellular signal to allow the cell to respond and 
communicate with neighboring cells
349
. In cancer, many of these receptors are often 
deregulated
350
. The ability to probe these overexpressed and/or mutated surface receptors 
can potentially be useful in probing of tumors, in monitoring disease progression, and 
assessing responsiveness to drug therapies
351
. 
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8.2.1 Probing Surface Receptors of Ovarian Cancer Cells  
 Studies have shown that the major pathways involved in development of ovarian 
cancer are the downstream pathways mediated by EGFR and LPAR (LPA receptor), a Gi-
coupled receptor
41, 352
. In this study, we used the QCM-D to examine the ligand-induced 
cellular response of EGFR and LPAR. When treated with 50 nM EGF, the SKOV-3 cells 
exhibited a time-dependent ΔD-response, which begins with a small initial increase, 
followed by a rapid decrease and then quickly transitions into a sharp increase until 
around 30 min. For the remaining time, the response virtually levels off (Figure 8.1A). 
The pattern of the EGF-induced ΔD-response of the SKOV-3 cells is similar to those of 
A431 cells and MCF10A cells obtained in previous studies
154, 155
. When treated with 1 
μM LPA, the SKOV-3 cells exhibited a time-dependent ΔD-response that was very 
distinct from the EGF-induced response: The profile first began with a large and steep 
increase for ~5 min, followed by a sharp decrease for ~10 min, and finally ended with a 
stable response close to the initial baseline level of the control, where the cells were not 
exposed to any LPA (Figure 8.1B). 
 There have been reports suggesting abnormal levels of thrombin and histamine 
found in ovarian cancer
333, 334
. Thrombin and histamine are small biomolecules that bind 
to PAR and histamine receptors, respectively, and both activate the Gq-coupled signaling 
pathway. Thus it is not surprising that both thrombin- and histamine-induced ΔD-
response profiles were very similar: They both begin with a rapid increase for 5 min, then 
a sharp decline in the next 5 min, then after a quick transition, a slow rise up to a stable 
level of response for the rest of the time (Figures 8.1C and 8.1D).  
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 The distinct ΔD-response profiles exhibited by these three types of receptors, 
EGFR (EGF), Gi-coupled receptor (LPA) and Gq-coupled receptor (thrombin and 
histamine) imply that the QCM-D has the ability to detect and differentiate cellular 
response mediated by various types of surface receptors. The fact that both thrombin and 
histamine belong to the same type of receptors and show similar ΔD-response profiles 
indicates that these response profiles represent the signature response of each type of 
receptor. These signature responses will be compared to the responses obtained by other 
label-free cell-based assays
102
 for the future study. 
 
 
 
 
Figure 8.1. Real-time QCM-D measurements (at the third mode of vibration) of the responses of SKOV-3 
cells to biomolecules at 37 °C. (A) The signature ΔD-response induced by 50 nM epidermal growth factor 
(EGF). (B) The signature ΔD-response induced by 1 μM lysophosphatidic acid (LPA). (C) The signature 
ΔD-response induced by 15 μM histamine (Hist). (D) The signature ΔD-response induced by 100 nM 
thrombin (Thr). (At least ten replicates were done of each experiment.) 
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8.2.2 Sensitivity of the ΔD-Response to Endogenous Biomolecules in Ovarian Cancer 
Cells 
 There is a need for highly sensitive and quantitative technologies to detect and 
characterize tumor tissue samples to provide faster reliable information on the diagnosis, 
prognosis, and targeted therapy for the patient. In this study, we tested biomolecules in 
the ranges of the physiological concentrations determined by others to explore the 
potential of the QCM-D for providing sensitive and quantitative information of specific 
biomarkers of ovarian cancer cells (Table 8.1). Both EGF and thrombin have been found 
in human serum in nanomolar levels, and we have successfully detected the ΔD-response 
induced by both EGF and thrombin in the range of 5-100 nM (Figures 8.2A and 8.2D). 
The physiological concentrations for LPA and histamine in human serum are in the 
micromolar range and we have successfully detected LPA and histamine in the range of 
0.5-20 µM and 0.25-15 µM, respectively (Figures 8.2B and 8.2C). In summary, we have 
demonstrated that the QCM-D is capable of detecting the cellular response in the form of 
a time-dependent ΔD-response profile induced by those endogenous biomolecules at the 
corresponding physiological concentration ranges. The QCM-D-based cell assay platform 
is highly sensitive toward the detection of the potential biomarkers so that a slightly 
abnormal change of the concentration of these biomarkers in the early stage of the disease 
development can be readily identified. This platform is also mechanistically informative 
because the ΔD-response profile is capable of revealing the type of signaling mechanism 
that biomarker could be involved. Overall, the ability to detect cellular responses within 
physiological concentration range can potentially be useful in studying patient samples 
and providing more accurate analysis of the main cause of the illness.  
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 In addition, the dose dependence of the ΔD-response of SKOV-3 cells allows us 
to derive the efficacy information for each biomarker in its role of activation of the 
membrane receptors for medical diagnosis and prognosis purposes.  
 
 
Table 8.1. Physiological concentration ranges of EGF, LPA, histamine and thrombin in human plasma and 
detection range of the QCM-D tested in the study.   
Biomolecule 
Physiological 
Concentration Range 
QCM-D Test 
Range 
Lowest Concentration 
Detected 
EGF Low nM 353 0-100 nM 1 nM 
LPA µM 354 0-20 µM 10 nM 
Histamine Low µM 355 0-15 µM 250 nM 
Thrombin nM 356 0-100 nM 5 nM 
 
 
 
 
 
Figure 8.2. Real-time QCM-D measurements of in the dose response of SKOV-3 cells. (A) Dose-
dependent ΔD-response induced by EGF. (B) Dose-dependent ΔD-response induced by LPA. (C) Dose-
dependent ΔD-response induced by histamine. (D) Dose-dependent ΔD-response induced by thrombin. 
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8.2.3 Comparison of Ligand-Induced ΔD-Responses in Various Cell Lines  
 It is known that various cell lines respond to stimulation differently. In this study, 
we compared the ligand-induced ΔD-responses of SKOV-3 cells, with those of MCF-
10A and A431 cells, to assess their similarities and differences that are important for 
biomarker detection. First of all, the EGF-induced ΔD-responses of all three cell lines 
show a similar initial sharp rise followed by a rapid decline down to a large negative 
level. The major difference of the three response profiles lies in the rise that occurs 
immediately after the large decline. For SKOV-3 cells, the response has a quick transition 
that leads to a sharp rise. For MCF10A cell and A431 cells, they both have a longer 
transition that leads to a gradual rise (Figures 8.3A-8.3C).  
As Gq-coupled ligands, histamine and thrombin were able to induce all three cell 
lines to give a ΔD-response profile with a sharp peak right from the beginning (Figures 
8.3G- 8.3L). This sharp peak also displays a signature decline phase, where the response 
drops down rapidly to about one half or two thirds of the peak height, then transitions to a 
more gradual decrease towards the baseline level. Overall, the initial sharp peak with a 
two-phase decline is the key feature for a typical Gq-coupled response. Whether being 
induced with histamine or thrombin, the response profile of each cell line shows very 
little difference. Between different cell lines, however, the response profiles exhibit a 
substantial difference in their transitions between the rapid and slow decline. For SKOV-
3 cells, the transition is very distinct and appears as a shallow valley. For MCF10A and 
A431 cells, there is no obvious transition and the slow decline appears immediately after 
the rapid one.  
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As a Gi-coupled ligand, LPA induced the cells to give a ΔD-response profile with 
a sharp peak right from the beginning (Figures 8.3D-8.3F), similar to the key feature of 
the typical Gq-coupled response (Figures 8.3G-8.3L). Unlike the Gq-coupled response, 
the Gi-coupled response has only a single decline phase with a deeper drop that may 
reach either at or far below the baseline level. The depth of the drop is cell-type 
dependent. 
In summary, the controls for all cell types responded very similarly to the 
biomarkers used. By contrast, the ligand-induced ΔD-responses are different for each 
specific cell type. These cell-type-specific ΔD-responses could be due to different 
receptor expression level and diversity of the receptor conformations and organizations in 
the different cell types
206
. Another reason for the different ΔD-responses could be the 
heterogeneity in the expression, organization, and interaction of the cytosolic components 
in the different cell types
357
. There are many examples in literature that a given receptor 
may prefer different signaling pathways in different cell types
357, 358
. Such signature 
QCM-D-response is highly sensitive and reliable for biomarker detection. The use of the 
QCM-D may provide an effective platform for medical diagnosis and prognosis.  
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Figure 8.3. Comparison of ligand-induced ΔD-responses of SKOV-3 cells, MCF-10A cells, and A431 
cells. (A-C) EGF-induced ΔD-responses in SKOV-3 cells, MCF-10A cells, and A431 cells, respectively. 
(D-F) LPA-induced ΔD-responses in SKOV-3 cells, MCF-10A cells, and A431 cells, respectively. (G-I) 
Thrombin-induced ΔD-responses in SKOV-3 cells, MCF-10A cells, and A431 cells, respectively. (J-L) 
Histamine-induced ΔD-responses in SKOV-3 cells, MCF-10A cells, and A431cells, respectively. In each 
figure above the black ΔD-responses is the control, which is cells in assay buffer. (At least ten replicates 
were done of each experiment.)  
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8.2.4 Assessing the Responsiveness to Pharmacological Modulators  
 Among the EGFR mediated pathways, the PI3K pathway is known to regulate 
cell adhesion. To obtain some insight into how the downstream PI3K pathway affects the 
EGF-induced cellular response, we inhibited the activity of specific signaling proteins in 
the PI3K pathway and assessed the effects of such inhibition on the EGF-induced ΔD-
responses.  
 First we probed the PI3K pathway by treating the SKOV-3 cells with LY294002 
and wortmannin, both are potent inhibitors of PI3K signaling protein. Figure 8.4 shows 
inhibition studies of the PI3K pathway. When the SKOV-3 cells were treated with 
LY294002, the EGF-induced ΔD-response showed a dose dependent reduction of the 
magnitude (Figure 8.4A). When the SKOV-3 cells were treated with wortmannin, the 
EGF-induced ΔD-response showed a dose dependent suppression of the ΔD-response 
between 5min – 30min (Figure 8.4D). From these results, we conclude that the QCM-D 
has the sensitivity to probe the effects of pharmacological modulators on the adhered 
cells within the range of concentration used in typical biochemical assays
52
. Next, we 
compared the effects of LY294002 and wortmannin on the EGFR mediated response in 
SKOV-3 cells with those of MCF-10A cells and A431 cells (Figure 8.4). Both LY294002 
and wortmannin were able to suppress the EGFR-mediated cellular responses in a dose-
dependent manner in all three cell lines. However, each of the three cell lines shows a 
unique inhibition pattern that appears to be cell-type dependent (Figure 8.4). We attribute 
this finding to the intricate difference in the signaling network of each individual cell 
type, even though both modulators target the PI3K pathway. For the same cell lines, 
inhibition patterns by either LY294002 or wortmannin are quite similar. This result is 
125 
 
 
 
consistent with the fact that both inhibitors target the same protein molecule PI3K of the 
same signaling pathway. Thus the QCM-D is capable of providing mechanistic 
information on how a drug molecule affects cellular function.   
 
 
 
 
Figure 8.4. ΔD-response vs. time showing the effect of two different pharmacological modulators 
(LY294002, top row and wortmannin, bottom row) on three different cell lines (SKOV-3 cells, MCF-10A 
cells and A431 cells) exposed to 10nM EGF. (A) SKOV-3 cells induced by EGF and suppressed by 1 µM 
and by 10 µM LY294002. (B) MCF10A cells induced by EGF and suppressed by 3 µM and by 10 µM 
LY294002. (C) A431 cells induced by EGF and suppressed by 1 µM and by 10 µM LY294002. (D) 
SKOV-3 cells induced by EGF and suppressed by 50 nM and by 100 nM wortmannin. (E) MCF10A cells 
induced by EGF and suppressed by 20 nM and by 70 nM wortmannin. (F) A431 cells induced by EGF and 
suppressed by 50 nM and by 100 nM wortmannin.  
 
 
8.3 Summary 
 Ovarian carcinoma consists of a variety of tumor cells with various 
histopathological features and varied biological behaviors
318
. Various reports have linked 
biomolecules, such as EGF, LPA, thrombin, and histamine, with the development of a 
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variety of ovarian cancers. In this study, we have demonstrated that the whole cell-based 
QCM-D assay has the sensitivity and specificity to assess the cellular response induced 
by these potential biomarkers of ovarian cancer. The QCM-D relies on the ΔD-response 
profiles induced by these biomarkers at physiological concentrations to reveal the 
signature of these biomarkers (Table 8.1). These sensitive, reliable, and informative 
signatures can be used for detecting biomarkers at relevant physiological concentrations 
and for providing mechanistic insight into their effects on ligand-receptor binding and/or 
specific type of cell signaling. A more accurate and reliable early detection of these and 
other biomarker may pave the way for the future development of an effective therapeutic 
treatment of ovarian cancer.  
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Chapter 9: Overall Summary  
The overall objective of this project was to apply the quartz crystal microbalance 
with dissipation monitoring (QCM-D) to the investigation of the properties of biological 
systems that are relevant to fundamental biology and future medical applications. The 
QCM-D is an ultrasensitive mechanical sensing device that is capable of providing real-
time, non-invasive measurements of the changes in frequency and energy dissipation of 
adhered cells. Over the past few decades, acoustic instruments, such as the QCM, have 
been used in biological and biomedical research. Much of these studies have been limited 
to a few areas of biological and biomedical research, such cell interaction with various 
surfaces and the effects of pharmaceuticals of cells. The capabilities of acoustic sensors 
can be further exploited to provide more insight into fundamental cell biology and to 
suggest future applications. The work reported in this dissertation describes the use of the 
QCM-D as a platform for the study of biological systems at cellular and tissue levels. 
Chapters 1, 2, and 3 gave an introduction to cell adhesion, presented basic 
principles of the QCM-D technology, and describe the materials and methods used in the 
experiments, respectively. 
Chapter 4 describes an examination of the cell de-adhesion process induced by 
epidermal growth factor receptor (EGFR) signaling. We revealed that this de-adhesion 
process is a complex process, including an initial fast cell de-adhesion, a transition, and 
finally, a slow re-adhesion. We found that three downstream pathways (MAPK/ERK, 
PI3K, and PLC) of EGFR signaling mediate the de-adhesion process. These results 
established a quantitative framework for the analysis of cell adhesion and established a 
functional output for studying cell signaling. 
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Chapter 5 describes an investigation of the adhesion process of cells to surfaces 
coated with titanium, a material commonly used for medical implants. In this chapter, a 
correlation of the ΔD-response and the three-stage adhesion process is demonstrated. We 
demonstrated that the adhesion of human epidermal keratinocytes can be affected in a 
variety of ways, such as coating the surface with fibronectin, stimulating the cells with 
growth factor, and modulating the cell signaling pathways with pharmacological 
molecules.  
Chapter 6 describes the examination of the cellular response mediated through the 
GPCR signaling. Characteristic patterns in the ΔD-response were found to each of the 
three signaling pathways (Gαq, Gαs, and Gαi). These characteristic ΔD-responses were then 
used to demonstrate signal coordination among pairs of GPCR signaling pathways. The 
EC50 values determined from the ΔD-response induced by GPCR ligands were compared 
with EC50 values obtained with other methods.  
Chapter 7 describes the investigation of the use of the QCM-D to detect and 
distinguish between subclasses of EGFR. Our study revealed that the ΔD-response is 
associated with the remodeling of the cytoskeleton and represents the cellular response to 
signaling mediated by high-affinity EGFR. The Δf-response is associated with the 
calcium influx and represents the cellular response to signaling mediated by low-affinity 
EGFR.  
Chapter 8 describes the detection of potential biomarkers of ovarian cancer with 
the QCM-D. Here we demonstrated that the cell-based QCM-D assay has the sensitivity 
and specificity to assess the cellular response induced by specific subclasses of EGFR 
and potential biomarkers of ovarian cancer.  
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The results presented demonstrated that the QCM-D is a highly sensitive, non-
invasive, and label-free technique that has the capabilities to explore a wide range of 
cellular processes, such as cell signaling and mechanotransduction. Conventional cell 
biology uses a simplified approach for the examination of cellular structure and function 
by examining one component at a time. This approach has not been very effective in 
dealing with the complexity of the cell. The ΔD-response is an integrated functional 
output of the cell that is regulated by the network of cell signaling. This makes the ΔD-
response of the QCM-D a novel approach for dealing with the complexity of the cell and 
for tracking the response of the signaling reaction that are responsible for the regulation 
of a particular cellular function. Another advantage of using the QCM-D as an approach 
to study cellular responses is the QCM-D can offer lots of information with one 
experiment that is because the QCM is a continuous monitor of cellular response in real-
time. This capability can potentially save money and on reagents, such as ligands and 
modulators. Therefore, with careful experimental design the QCM-D can probe cellular 
responses and combined with other conventional techniques can potentially provide 
further insight on cellular events. Further development of QCM-D as a cell sensing 
platform can also potentially advance its use in clinical applications such as biomarker 
detection and testing for personalized treatment of a disease.   
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Chapter 10:  Future Work  
 
 Although the work described in this dissertation demonstrated the QCM-D is a 
useful technique in studying cell adhesion, there are still numerous experiments that 
should be done. Some future experiments are described below.   
In order to confirm the reliability of the QCM-D as a sensing platform for 
screening drugs, other inhibitors that affect the EGFR downstream signaling pathways 
should be tested. The inhibitors selected should target various signaling molecules within 
each downstream signaling pathway.  
In order to verify the dependability of the QCM-D as a sensing platform for the 
adhesion of cells on implant materials, a future study of other surface coatings and other 
pharmacological modulators that specifically target cell adhesion molecules should be 
examined. Different metal, polymer, and ceramic substrates should be tested.      
Many of the GPCR ligands examined in this study can potentially induce off-
target effects. Future studies using genetically altered cells would be expected to shed 
light on off-target effects on the ligand-induced ΔD-responses. 
To further validate the specificity and sensitivity of the QCM-D for biomarker 
detection, a study on a mixture of biomarkers and proteins as a mock body fluid sample 
should be conducted.      
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Appendix 
 
AI.  Abbreviations 
7TM  Seven Transmembrane Domain Receptors 
AC  Adenylyl Cyclase 
AFM   Atomic Force Microscopy 
ATP  Adenosine triphosphate 
BFP  Biomembrane Probe 
BioCD  Bio-optical Compact Disc 
BP  Bullous Pemphigoid 
BSA   Bovine Serum Albumin 
CAM  cell adhesion molecule 
cAMP  3’,5’-cyclic adenosine monophosphate 
CD  Cytochalasin D 
Cr  Chromium 
CRP  complement regulatory protein  
CTX  Chloera Toxin 
CVI  Cell Viscoelastic Index 
D   Dissipation 
DAG  Diacylglycerol 
DMEM  Dulbecco’s modified Eagle’s medium 
DMEM/F12  Dulbecco’s modified Eagle’s medium: nutrient mix F12 
ECIS   Electric Cell-Substrate Impedance Sensing 
ECM   Extra Cellular Matrix 
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EDTA  Ethylenediaminetetraacetic acid 
EGF   Epidermal Growth Factor 
EGFR   Epidermal Growth Factor Receptor 
EGTA  Ethylene Glycol Tetraacetic Acid 
ELISA  Enzyme-linked Immunosorbent Assay 
Epi  Epinephrine 
f   Frequency 
FA   Focal Adhesions 
FAK   Focal Adhesion kinases 
FBS   Fetal Bovine Serum 
FN  Fibronectin 
GDP  Guanidine Diphosphate 
GFP  Green Fluorescent Protein 
GTP   Guanidine Triphosphate 
GPCR   G protein Coupled Receptor 
HBSS   Hanks Balanced Salt Solution 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HER  Human Epidermal Growth Factor Receptor 
Hist  Histamine 
IF  Intermediate Filament 
Ig  Immunoglobin 
IP3  Inositol-1,4,5-trisphosphate 
ISO  Isoproterenol 
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LPA  Lysophosphatidic Acid 
MAPK  Mitogen Activated Protein Kinase 
MgCl2  Magnesium Chloride 
MLC  Myosin Light Chain  
MMP  Matrix Metalloproteinase 
NA  Nicotinic Acid 
NECA  5'-N-Ethylcarboxamidoadenosine 
PA-TFM Polyacrylamide (PA) Gel-based Traction Force Microscopy 
PBS   Phosphate Saline Buffer 
PFA   Paraformaldehyde 
PI3K   Phosphoinositide 3-Kinase 
PIP2   Phosphoinositol 4,5-bisphosphate 
PIPES   Piperazine-N,N’-bis(2-ethanesulfonic acid) 
PKC  Protein Kinase C 
PLCγ   Phospholipase C Gamma 
PTX  Pertussis Toxin  
QCM   Quartz Crystal Microbalance 
QCM-D  Quartz Crystal Microbalance with Dissipation 
RBC  Red Blood Cell 
RTK   Receptor Tyrosine Kinases 
SCFS  Single Cell Force Spectroscopy 
SDS   Sodium Dodecyl Sulfate 
SPR   Surface Plasmon Resonance 
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SRE  Serum Response Element 
STAT  Signal Transducer and Activator of Transcription 
Ta  Tantalum 
TGF-α  Transforming Growth Factor-α 
TIRF   Total Internal Reflection fluorescence Microscopy 
Thr   Thrombin 
YM  YM-254890 
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